<html lang="en" class="js-enable"><head><script async="" type="text/javascript" id="cX_csd_domainScript" src="https://csm.cxpublic.com/KIRIN/domain/www.kyowakirin.com.js?2022082222"></script>
<meta charset="UTF-8">
<title>What we do - Kyowa Kirin</title>
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="format-detection" content="telephone=no">
<meta name="description" content="Through a robust pipeline of promising drug candidates, pharmaceutical innovator Kyowa Kirin aims to ensure people around the world have access to safe, effective treatment. This page describes the company's research, technologies, and development schedules.">
<meta property="og:title" content="What we do - Kyowa Kirin">
<meta property="og:description" content="Through a robust pipeline of promising drug candidates, pharmaceutical innovator Kyowa Kirin aims to ensure people around the world have access to safe, effective treatment. This page describes the company's research, technologies, and development schedules.">
<meta property="og:image" content="https://www.kyowakirin.com/share/images/img_ogp.png">
<meta property="og:type" content="website">
<link rel="shortcut icon" href="/share/images/favicon.ico">
<link rel="apple-touch-icon" href="/share/images/apple_touch_icon.png">
<link rel="stylesheet" href="/share/css/outBoundModal.css">
<link rel="stylesheet" href="/share/css/common.css">
<link rel="stylesheet" href="/share/css/kkc-animation.css">
<link rel="canonical" href="https://www.kyowakirin.com/what_we_do/index.html">
<script type="text/javascript" async="" src="https://cdn.cxense.com/cx.js"></script><script type="text/javascript" async="" src="https://cdn.cxense.com/cx.cce.js"></script><script type="text/javascript" async="" src="https://www.google-analytics.com/plugins/ua/linkid.js"></script><script type="text/javascript" async="" src="https://penta.a.one.impact-ad.jp/dd?oid=633b02ab034d8d97&amp;rft=k&amp;jsonp=TDWrapper_.tdw_50jy0c.dmpCb.list.aone.onReceive&amp;tgsrc=td"></script><script type="text/javascript" async="" src="https://cdn.treasuredata.com/sdk/2.4/td.min.js"></script><script type="text/javascript" async="" src="https://www.google-analytics.com/analytics.js"></script><script type="text/javascript" async="" src="https://www.googletagmanager.com/gtag/js?id=G-FER8866KER&amp;l=dataLayer&amp;cx=c"></script><script type="text/javascript" async="" src="https://www.googletagmanager.com/gtag/js?id=G-36R8JFJ0GF&amp;l=dataLayer&amp;cx=c"></script><script type="text/javascript" async="" src="https://cache.dga.jp/s/kirin/search_tool_n3_new.js"></script><script async="" src="//www.googletagmanager.com/gtm.js?id=GTM-5MRQQG"></script><script src="/share/js/init.js"></script>
<script async="" src="https://www.kyowakirin.co.jp/share/js/settrack.js" defer=""></script>
<script src="/share/js/stickyfill.min.js"></script>
<script src="https://cdn-apac.onetrust.com/scripttemplates/6.32.0/otBannerSdk.js" async="" type="text/javascript"></script><style type="text/css">#cce-empty-element {margin: 20px auto;width: 100%;text-align: center;}</style><style id="onetrust-style">#onetrust-banner-sdk{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-image:url("data:image/svg+xml;base64,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");background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:0.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type="checkbox"]:checked,#onetrust-pc-sdk [type="checkbox"]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type="checkbox"]:disabled+label::before,#onetrust-pc-sdk [type="checkbox"]:disabled+label:after,#onetrust-pc-sdk [type="checkbox"]:disabled+label{pointer-events:none;opacity:0.7}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type="checkbox"]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type="checkbox"]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px 0.1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#68b631;border:1px solid #68b631;height:auto;white-space:normal;word-wrap:break-word;padding:0.8em 2em;font-size:0.8em;line-height:1.2;cursor:pointer;-moz-transition:0.1s ease;-o-transition:0.1s ease;-webkit-transition:1s ease;transition:0.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#68b631}.onetrust-pc-dark-filter{background:rgba(0,0,0,0.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px) and (max-width: 896px) and (orientation: landscape){#onetrust-pc-sdk p{font-size:0.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}
#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}
#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media (min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media (min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media (min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:0.9em;font-weight:400;line-height:38px;letter-spacing:0.01em;text-decoration:none;white-space:nowrap;background-color:transparent;border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{color:#333;border-color:#888;opacity:0.7}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type="text"],#onetrust-pc-sdk input[type="text"],#ot-sdk-cookie-policy input[type="text"]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type="text"],#onetrust-pc-sdk input[type="text"],#ot-sdk-cookie-policy input[type="text"]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type="text"]:focus,#onetrust-pc-sdk input[type="text"]:focus,#ot-sdk-cookie-policy input[type="text"]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:0.5rem;font-weight:600}#onetrust-banner-sdk input[type="checkbox"],#onetrust-pc-sdk input[type="checkbox"],#ot-sdk-cookie-policy input[type="checkbox"]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}
#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid transparent;border-bottom:6px solid transparent;border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFFFFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header {
                        color: #5D6164;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #1BA8D6;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #EA5504;border-color: #EA5504;
                color: #FFFFFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #EA5504; border-color: #EA5504;
                background-color: 
                #FFFFFF;
            }#onetrust-pc-sdk{position:fixed;width:730px;max-width:730px;height:610px;left:0;right:0;top:0;bottom:0;margin:auto;font-size:16px;z-index:2147483647;border-radius:2px;background-color:#fff;box-shadow:0 2px 4px 0 rgba(0,0,0,0),0 7px 14px 0 rgba(50,50,93,.1)}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before{box-sizing:content-box}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 185px)}#onetrust-pc-sdk li{list-style:none}#onetrust-pc-sdk ul,#onetrust-pc-sdk li{margin:0}#onetrust-pc-sdk a{text-decoration:none}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk .ot-grps-cntr *::-webkit-scrollbar,#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-grps-cntr *::-webkit-scrollbar-thumb,#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-pc-sdk .ot-grps-cntr *,#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-pc-sdk .ot-pc-header{height:auto;padding:10px;display:block;width:calc(100% - 20px);min-height:52px;border-bottom:1px solid #d8d8d8;position:relative}#onetrust-pc-sdk .ot-pc-logo{display:inline-block;vertical-align:middle;width:180px}#onetrust-pc-sdk .ot-pc-logo.ot-pc-logo{height:40px}#onetrust-pc-sdk .ot-title-cntr{position:relative;display:inline-block;vertical-align:middle;width:calc(100% - 190px);padding-left:10px}#onetrust-pc-sdk .ot-always-active{font-size:.813em;line-height:1.5;font-weight:700;color:#3860be}#onetrust-pc-sdk .ot-close-cntr{float:right;position:absolute;right:-9px;top:50%;transform:translateY(-50%)}#onetrust-pc-sdk #ot-pc-content{position:relative;overflow-y:auto;overflow-x:hidden}#onetrust-pc-sdk .ot-grps-cntr,#onetrust-pc-sdk .ot-grps-cntr>*{height:100%;overflow-y:auto}#onetrust-pc-sdk .category-menu-switch-handler{cursor:pointer;border-left:10px solid transparent;background-color:#f4f4f4;border-bottom:1px solid #d7d7d7;padding-top:12px;padding-right:5px;padding-bottom:12px;padding-left:12px;overflow:hidden}#onetrust-pc-sdk .category-menu-switch-handler h3{float:left;text-align:left;margin:0;color:dimgray;line-height:1.4;font-size:.875em;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-active-menu{border-left:10px solid #68b631;background-color:#fff;border-bottom:none;position:relative}#onetrust-pc-sdk .ot-active-menu h3{color:#263238;font-weight:bold}#onetrust-pc-sdk .ot-desc-cntr{word-break:break-word;word-wrap:break-word;padding-top:20px;padding-right:16px;padding-bottom:15px}#onetrust-pc-sdk .ot-grp-desc{word-break:break-word;word-wrap:break-word;text-align:left;font-size:.813em;line-height:1.5;margin:0}#onetrust-pc-sdk .ot-grp-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc a{color:#3860be;cursor:pointer;font-size:1em;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc a:hover{color:#1883fd}#onetrust-pc-sdk #ot-pc-desc button{margin-right:8px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-desc+.ot-link-btn{display:none}#onetrust-pc-sdk .ot-btn-subcntr{float:right}#onetrust-pc-sdk .ot-close-icon{background-image:url("data:image/svg+xml;base64,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");background-size:12px;background-repeat:no-repeat;background-position:center;height:44px;width:44px;display:inline-block}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#cddcf2}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(16px);-ms-transform:translateX(16px);transform:translateX(16px);background-color:#4285f4}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob:before{box-shadow:0 0 1px #2196f3;outline-style:auto;outline-width:1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:35px;height:10px;margin-bottom:0}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#f2f1f1;border:none;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:46px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:20px;width:20px;bottom:1px;background-color:#7d7d7d;-webkit-transition:.4s;border-radius:100%;top:-5px;transition:.4s}#onetrust-pc-sdk .ot-chkbox{z-index:1;position:relative}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox label{position:relative;height:20px;padding-left:30px;display:inline-block;cursor:pointer}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-fltr-opt .ot-label-txt{display:block}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-label-status{font-size:.75em;position:relative;top:2px;display:none;padding-right:5px;float:left}#onetrust-pc-sdk #ot-lst-cnt .ot-label-status{top:-6px}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px;overflow:hidden;margin-right:15px}#onetrust-pc-sdk .ot-fltr-btns button{padding:12px 30px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pc-footer button{margin-top:20px;margin-bottom:20px;font-weight:600;font-size:.813em;min-height:40px;height:auto;line-height:normal;padding:10px 30px}#onetrust-pc-sdk .ot-tab-desc{margin-left:3%}#onetrust-pc-sdk .ot-grp-hdr1{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-desc-cntr h4{color:#263238;display:inline-block;vertical-align:middle;margin:0;font-weight:bold;font-size:.875em;line-height:1.3;max-width:70%}#onetrust-pc-sdk #ot-pvcy-hdr{margin-bottom:10px}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-host-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{display:block;float:left;color:#3860be;font-size:.813em;font-weight:400;line-height:1.1;cursor:pointer;margin:5px 0px}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-host-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover{color:#1883fd}#onetrust-pc-sdk .category-vendors-list-handler+a::after{content:"";height:17px;width:15px;background-repeat:no-repeat;margin-left:2px;margin-top:-1px;float:right;background-image:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 511.626 511.627'%3E%3Cg fill='%231276CE'%3E%3Cpath d='M392.857 292.354h-18.274c-2.669 0-4.859.855-6.563 2.573-1.718 1.708-2.573 3.897-2.573 6.563v91.361c0 12.563-4.47 23.315-13.415 32.262-8.945 8.945-19.701 13.414-32.264 13.414H82.224c-12.562 0-23.317-4.469-32.264-13.414-8.945-8.946-13.417-19.698-13.417-32.262V155.31c0-12.562 4.471-23.313 13.417-32.259 8.947-8.947 19.702-13.418 32.264-13.418h200.994c2.669 0 4.859-.859 6.57-2.57 1.711-1.713 2.566-3.9 2.566-6.567V82.221c0-2.662-.855-4.853-2.566-6.563-1.711-1.713-3.901-2.568-6.57-2.568H82.224c-22.648 0-42.016 8.042-58.102 24.125C8.042 113.297 0 132.665 0 155.313v237.542c0 22.647 8.042 42.018 24.123 58.095 16.086 16.084 35.454 24.13 58.102 24.13h237.543c22.647 0 42.017-8.046 58.101-24.13 16.085-16.077 24.127-35.447 24.127-58.095v-91.358c0-2.669-.856-4.859-2.574-6.57-1.713-1.718-3.903-2.573-6.565-2.573z'/%3E%3Cpath d='M506.199 41.971c-3.617-3.617-7.905-5.424-12.85-5.424H347.171c-4.948 0-9.233 1.807-12.847 5.424-3.617 3.615-5.428 7.898-5.428 12.847s1.811 9.233 5.428 12.85l50.247 50.248-186.147 186.151c-1.906 1.903-2.856 4.093-2.856 6.563 0 2.479.953 4.668 2.856 6.571l32.548 32.544c1.903 1.903 4.093 2.852 6.567 2.852s4.665-.948 6.567-2.852l186.148-186.148 50.251 50.248c3.614 3.617 7.898 5.426 12.847 5.426s9.233-1.809 12.851-5.426c3.617-3.616 5.424-7.898 5.424-12.847V54.818c-.001-4.952-1.814-9.232-5.428-12.847z'/%3E%3C/g%3E%3C/svg%3E")}#onetrust-pc-sdk .category-host-list-handler,#onetrust-pc-sdk .ot-vlst-cntr,#onetrust-pc-sdk #ot-pc-desc+.category-vendors-list-handler{margin-top:8px}#onetrust-pc-sdk .ot-grp-hdr1+.ot-vlst-cntr{margin-top:0px;margin-bottom:10px}#onetrust-pc-sdk .ot-always-active-group h3.ot-cat-header,#onetrust-pc-sdk .ot-subgrp.ot-always-active-group>h4{max-width:70%}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr{max-width:28%}#onetrust-pc-sdk .ot-grp-desc ul,#onetrust-pc-sdk li.ot-subgrp p ul{margin:0px;margin-left:15px;padding-bottom:8px}#onetrust-pc-sdk .ot-grp-desc ul li,#onetrust-pc-sdk li.ot-subgrp p ul li{font-size:inherit;padding-top:8px;display:list-item;list-style:disc}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:inherit}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none;position:relative}#onetrust-pc-sdk ul.ot-subgrps li h4,#onetrust-pc-sdk ul.ot-subgrps li p{font-size:.82em;line-height:1.4}#onetrust-pc-sdk ul.ot-subgrps li p{color:dimgray;clear:both;float:left;margin-top:10px;margin-bottom:0;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul.ot-subgrps li h4{color:#263238;font-weight:bold;margin-bottom:0;float:left;position:relative;top:3px}#onetrust-pc-sdk li.ot-subgrp{margin-left:30px;display:inline-block;width:calc(100% - 30px)}#onetrust-pc-sdk .ot-subgrp-tgl{float:right}#onetrust-pc-sdk .ot-subgrp-tgl.ot-always-active-subgroup{width:auto}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4;border-radius:0 0 2px 2px}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk #accept-recommended-btn-handler{float:right;text-align:center}#onetrust-pc-sdk .save-preference-btn-handler{min-width:155px;background-color:#68b631;border-radius:2px;color:#fff;font-size:.9em;line-height:1.1;text-align:center;margin-left:15px;margin-right:15px}#onetrust-pc-sdk .ot-btn-subcntr button{margin-right:16px}#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr{max-width:40%;white-space:normal;text-align:center}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button{margin-left:auto;margin-right:auto;min-width:60%;max-width:90%}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button:nth-child(2){margin-top:0}#onetrust-pc-sdk.ot-ftr-stacked #accept-recommended-btn-handler{float:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{overflow:hidden}#onetrust-pc-sdk #ot-pc-title{margin:0px;overflow:hidden;position:relative;line-height:1.2;max-height:2.4em;padding-right:1em;font-size:1.37em;text-overflow:ellipsis;white-space:nowrap;display:block;max-width:90%}#onetrust-pc-sdk #ot-pc-title.ot-pc-title-shrink{max-width:70%}#onetrust-pc-sdk #ot-pc-lst{width:100%;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{padding-top:17px;padding-right:15px;padding-bottom:17px;padding-left:20px;display:inline-block;width:calc(100% - 35px);vertical-align:middle}#onetrust-pc-sdk #ot-pc-lst .ot-acc-txt{padding-top:6px;padding-right:15px;padding-bottom:10px;padding-left:20px}#onetrust-pc-sdk .ot-lst-cntr{height:100%}#onetrust-pc-sdk #ot-pc-hdr{padding-top:15px;padding-right:30px;padding-bottom:15px;padding-left:20px;display:inline-block;width:calc(100% - 50px);height:20px;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk #ot-pc-hdr input{height:32px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#d4d4d4;font-style:italic}#onetrust-pc-sdk #ot-lst-cnt{height:calc(100% - 86px);padding-left:30px;padding-right:27px;padding-top:20px;margin-top:8px;margin-right:3px;margin-bottom:4px;margin-left:0;overflow-x:hidden;overflow-y:auto;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk #ot-lst-title{display:inline-block;font-size:1em}#onetrust-pc-sdk #ot-lst-title h3{color:dimgray;font-weight:bold;margin-left:10px;display:inline-block;font-size:1em}#onetrust-pc-sdk #ot-lst-title h3 *{font-size:inherit}#onetrust-pc-sdk .ot-lst-subhdr{float:right;position:relative;bottom:6px}#onetrust-pc-sdk #ot-search-cntr{display:inline-block;vertical-align:middle;position:relative;width:300px}#onetrust-pc-sdk #ot-search-cntr svg{position:absolute;right:0px;width:30px;height:30px;font-size:1em;line-height:1;top:2px}#onetrust-pc-sdk #ot-fltr-cntr{display:inline-block;position:relative;margin-left:20px;vertical-align:middle;font-size:0}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;width:32px;height:32px;padding:0;margin:0;position:relative}#onetrust-pc-sdk #filter-btn-handler svg{cursor:pointer;width:15px;height:15px;position:absolute;left:50%;top:50%;transform:translate(-50%, -50%);padding-top:5px}#onetrust-pc-sdk #filter-btn-handler path{fill:#fff}#onetrust-pc-sdk #ot-sel-blk{min-width:200px;min-height:30px;padding-left:20px}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr{float:left;height:100%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label{height:100%;padding-left:0}#onetrust-pc-sdk #ot-selall-hostcntr{width:21px;height:21px;position:relative;left:20px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;left:5px;top:10.5px;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none}#onetrust-pc-sdk .ot-ven-name,#onetrust-pc-sdk .ot-host-name{color:#2c3643;font-weight:bold;font-size:.813em;line-height:1.2;margin:0;height:auto;text-align:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-name *,#onetrust-pc-sdk .ot-host-name *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc{font-size:.69em;line-height:1.4;margin-top:5px;margin-bottom:5px;color:dimgray}#onetrust-pc-sdk .ot-host-name>a{text-decoration:underline;position:relative;z-index:2;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk .ot-host-hdr{float:left;width:calc(100% - 50px);pointer-events:none;position:relative;z-index:1}#onetrust-pc-sdk .ot-host-hdr .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr a{pointer-events:initial}#onetrust-pc-sdk .ot-host-hdr .ot-host-name~a{margin-top:5px;font-size:.813em;text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:88%;float:right}#onetrust-pc-sdk input:focus+.ot-acc-hdr{outline:#000 solid 1px !important}#onetrust-pc-sdk #ot-selall-hostcntr input[type=checkbox],#onetrust-pc-sdk #ot-selall-vencntr input[type=checkbox],#onetrust-pc-sdk #ot-selall-adtlvencntr input[type=checkbox]{position:absolute}#onetrust-pc-sdk .ot-host-item .ot-chkbox{float:left}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-hdr{right:38px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:auto;padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{right:2px;width:auto}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>.ot-acc-hdr{background:#f9f9fc;padding-top:10px;padding-bottom:10px;background-color:#f9f9fc}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk #ot-pc-lst .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk #ot-addtl-venlst .ot-tgl-cntr{margin-right:13px}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;display:inline-block}#onetrust-pc-sdk .ot-ven-item>button:focus,#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-ven-item>button,#onetrust-pc-sdk .ot-host-item>button,#onetrust-pc-sdk .ot-acc-cntr>button{position:absolute;cursor:pointer;width:100%;height:100%;border:0;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-ven-item>button~.ot-acc-hdr,#onetrust-pc-sdk .ot-host-item>button~.ot-acc-hdr,#onetrust-pc-sdk .ot-acc-cntr>button~.ot-acc-hdr{cursor:pointer}#onetrust-pc-sdk .ot-ven-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-host-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-ven-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-host-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;display:block}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk #ot-ven-lst,#onetrust-pc-sdk #ot-host-lst,#onetrust-pc-sdk #ot-addtl-venlst,#onetrust-pc-sdk #ot-gn-venlst{width:100%}#onetrust-pc-sdk #ot-ven-lst li,#onetrust-pc-sdk #ot-host-lst li,#onetrust-pc-sdk #ot-addtl-venlst li,#onetrust-pc-sdk #ot-gn-venlst li{border:1px solid #d7d7d7;border-radius:2px;position:relative;margin-top:10px}#onetrust-pc-sdk #ot-gn-venlst li.ot-host-info{padding:.5rem;overflow-y:hidden}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{width:65%}#onetrust-pc-sdk #ot-host-lst .ot-tgl-cntr{width:65%;float:left}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk .ot-host-notice{float:right}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-host-expand{color:dimgray;font-size:.75em;line-height:.9;display:inline-block}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link{position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #e9e9e9}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h4{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h4{display:inline-block}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h4,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h4{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h4{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk .ot-host-opt{display:inline-block;width:100%;margin:0;font-size:inherit}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.81em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #ot-host-lst li.ot-host-info{border:none;font-size:.8em;color:dimgray;float:left;text-align:left;padding:10px;margin-bottom:10px;width:calc(100% - 10px);background-color:#f8f8f8}#onetrust-pc-sdk #ot-host-lst li.ot-host-info a{color:dimgray}#onetrust-pc-sdk #ot-host-lst li.ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk .ot-tgl-cntr{display:inline-block;vertical-align:middle}#onetrust-pc-sdk .ot-arw-cntr,#onetrust-pc-sdk .ot-tgl-cntr{float:right}#onetrust-pc-sdk .ot-desc-cntr{padding-top:0px;margin-top:20px;padding-right:0px;border-radius:3px;overflow:hidden;padding-bottom:10px}#onetrust-pc-sdk .ot-desc-cntr:focus,#onetrust-pc-sdk .ot-desc-cntr:active,#onetrust-pc-sdk .ot-desc-cntr:focus-visible{outline:2px solid #101010;border-radius:2px}#onetrust-pc-sdk .ot-leg-border-color{border:1px solid #e9e9e9}#onetrust-pc-sdk .ot-leg-border-color .ot-subgrp-cntr{border-top:1px solid #e9e9e9;padding-bottom:10px}#onetrust-pc-sdk .ot-category-desc{padding-bottom:10px}#onetrust-pc-sdk .ot-grp-hdr1{padding-left:10px;width:calc(100% - 20px);padding-top:10px;margin-bottom:0px;padding-bottom:8px}#onetrust-pc-sdk .ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk .ot-desc-cntr>*:not(.ot-grp-hdr1){padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-pli-hdr{overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;background-color:#f8f8f8;border:none;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-pli-hdr span:first-child{text-align:left;max-width:80px;padding-right:5px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:20px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-desc-cntr .ot-tgl-cntr:first-of-type,#onetrust-pc-sdk .ot-cat-header+.ot-tgl{padding-left:7px;padding-right:7px}#onetrust-pc-sdk .ot-always-active-group .ot-grp-hdr1 .ot-tgl-cntr:first-of-type{padding-left:0px}#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk .ot-subgrp h4{max-width:calc(100% - 133px)}#onetrust-pc-sdk #ot-lst-cnt #ot-sel-blk{width:100%;display:inline-block;padding:0}#onetrust-pc-sdk .ot-sel-all{display:inline-block;width:100%}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{width:100%;float:right;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk :not(.ot-hosts-ui) .ot-sel-all-hdr,#onetrust-pc-sdk :not(.ot-hosts-ui) .ot-sel-all-chkbox{right:23px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.813em;position:relative;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-hosts-ui .ot-consent-hdr{float:left;position:relative;left:5px}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;margin-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:10px}#onetrust-pc-sdk .ot-ven-litgl{margin-right:55px}#onetrust-pc-sdk .ot-ven-litgl.ot-ven-litgl-only{margin-right:86px}#onetrust-pc-sdk .ot-ven-ctgl,#onetrust-pc-sdk .ot-ven-litgl,#onetrust-pc-sdk .ot-ven-gvctgl{float:left}#onetrust-pc-sdk .ot-ven-ctgl label,#onetrust-pc-sdk .ot-ven-litgl label,#onetrust-pc-sdk .ot-ven-gvctgl label{width:22px;padding:0}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:21px;position:relative;float:right;right:80px}#onetrust-pc-sdk #ot-selall-licntr input{position:absolute}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-gnvencntr{float:right;width:21px;height:21px;position:relative;right:15px}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{float:right;width:auto}#onetrust-pc-sdk .ot-ven-hdr{float:left;width:60%}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk #ot-anchor{border:12px solid transparent;display:none;position:absolute;z-index:2147483647;top:40px;right:35px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk #ot-fltr-modal{width:300px;position:absolute;z-index:2147483646;top:46px;height:90%;max-height:350px;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal button{max-width:200px;line-height:1;word-break:break-word;white-space:normal;height:auto;font-weight:bold}#onetrust-pc-sdk #ot-fltr-cnt{background-color:#fff;margin:5px;border-radius:3px;height:100%;margin-right:10px;padding-right:10px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:25px;margin-left:15px;clear:both}#onetrust-pc-sdk .ot-fltr-opt label{height:auto}#onetrust-pc-sdk .ot-fltr-opt span{cursor:pointer;color:dimgray;font-size:.8em;line-height:1.1;font-weight:normal}#onetrust-pc-sdk #clear-filters-handler{float:right;margin-top:15px;margin-bottom:10px;text-decoration:none;color:#3860be;font-size:.9em;border:none;padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#1883fd}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk #filter-apply-handler{margin-right:10px}#onetrust-pc-sdk .ot-grp-desc+.ot-leg-btn-container{margin-top:0}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;line-height:normal;letter-spacing:0}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{border:none;text-decoration:underline;padding:0;font-size:.82em;font-weight:600;line-height:1.4;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:.91em;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;width:auto}#onetrust-pc-sdk.ot-close-btn-link .ot-close-cntr{right:5px;top:5px;transform:none}#onetrust-pc-sdk .ot-grps-cntr{overflow-y:hidden}#onetrust-pc-sdk.otPcTab[dir=rtl] input~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk.otPcTab[dir=rtl] #ot-back-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] #ot-search-cntr svg{right:15px}#onetrust-pc-sdk.otPcTab[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{padding:0;background-color:transparent;border:none;margin:0}@media(max-width: 767px){#onetrust-pc-sdk{width:100%;border:none}#onetrust-pc-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container{padding:0;margin:0}#onetrust-pc-sdk #ot-pc-title{margin-left:10px;max-width:60%}#onetrust-pc-sdk .ot-desc-cntr{margin:0;padding-top:20px;padding-right:20px;padding-bottom:15px;padding-left:20px;position:relative;left:auto}#onetrust-pc-sdk .ot-desc-cntr{margin-top:20px;margin-left:20px;padding:0;padding-bottom:10px}#onetrust-pc-sdk .ot-grps-cntr{max-height:none;overflow:hidden}#onetrust-pc-sdk #accept-recommended-btn-handler{float:none}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}#onetrust-pc-sdk.ot-tgl-with-label.ot-leg-opt-out .ot-pli-hdr{padding-right:8%}#onetrust-pc-sdk.ot-tgl-with-label .ot-cat-header{max-width:60%}#onetrust-pc-sdk.ot-tgl-with-label .ot-subgrp h4{max-width:58%}#onetrust-pc-sdk.ot-tgl-with-label .ot-desc-cntr .ot-tgl-cntr:first-of-type,#onetrust-pc-sdk.ot-tgl-with-label .ot-cat-header+.ot-tgl{padding-left:15px}}@media(max-width: 640px){#onetrust-pc-sdk{height:100%}#onetrust-pc-sdk .ot-pc-header{padding:10px;width:calc(100% - 20px)}#onetrust-pc-sdk #ot-pc-content{overflow:auto}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-columns{width:100%}#onetrust-pc-sdk .ot-desc-cntr{margin:0;overflow:hidden}#onetrust-pc-sdk .ot-desc-cntr{margin-left:10px;width:calc(100% - 15px);margin-top:5px;margin-bottom:5px}#onetrust-pc-sdk .ot-ven-hdr{max-width:80%}#onetrust-pc-sdk #ot-lst-cnt{width:calc(100% - 18px);padding-top:13px;padding-right:5px;padding-left:10px}#onetrust-pc-sdk .ot-grps-cntr{width:100%}#onetrust-pc-sdk .ot-pc-footer{max-height:300px}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 322px)}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{position:fixed;top:10px;right:15px}#onetrust-pc-sdk.ot-close-btn-link .ot-pc-header{padding-top:25px}#onetrust-pc-sdk.ot-close-btn-link #ot-pc-title{max-width:100%}}@media(max-width: 640px)and (orientation: portrait){#onetrust-pc-sdk #ot-pc-hdr{height:70px;padding:15px 0;width:100%}#onetrust-pc-sdk .ot-lst-subhdr{width:calc(100% - 15px);float:none;bottom:auto;display:inline-block;padding-top:8px;padding-left:15px}#onetrust-pc-sdk .ot-btn-subcntr{float:none}#onetrust-pc-sdk #ot-search-cntr{display:inline-block;width:calc(100% - 55px);position:relative}#onetrust-pc-sdk #ot-anchor{top:75px;right:30px}#onetrust-pc-sdk #ot-fltr-modal{top:81px}#onetrust-pc-sdk #ot-fltr-cntr{float:right;right:15px}#onetrust-pc-sdk #ot-lst-title{padding-left:15px}#onetrust-pc-sdk .ot-lst-cntr{overflow-y:scroll}#onetrust-pc-sdk #ot-lst-cnt{height:auto;overflow:hidden}#onetrust-pc-sdk .save-preference-btn-handler,#onetrust-pc-sdk #accept-recommended-btn-handler,#onetrust-pc-sdk .ot-pc-refuse-all-handler{width:calc(100% - 33px)}#onetrust-pc-sdk.ot-ftr-stacked .save-preference-btn-handler,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr{max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{margin:15px}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button{min-width:none;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-subcntr button:nth-child(2){margin-top:15px}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container button:not(:last-child){margin-bottom:0}}@media(max-width: 425px){#onetrust-pc-sdk #ot-pc-lst .ot-acc-txt{padding-top:6px;padding-bottom:10px}#onetrust-pc-sdk #ot-pc-lst .ot-host-notice{float:left;margin-left:30px}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:none;display:inline}#onetrust-pc-sdk #ot-pc-lst .ot-ven-hdr{float:left;width:100%;max-width:85%}#onetrust-pc-sdk.ot-addtl-vendors #ot-pc-lst .ot-acc-cntr .ot-arw-cntr:first-of-type{float:right}#onetrust-pc-sdk #ot-pc-title{max-width:100%}#onetrust-pc-sdk .ot-subgrp-cntr li.ot-subgrp{margin-left:10px;width:calc(100% - 10px)}#onetrust-pc-sdk #ot-ven-lst .ot-tgl-cntr{width:auto;float:right}#onetrust-pc-sdk #ot-ven-lst .ot-arw-cntr{float:right}#onetrust-pc-sdk .ot-ven-hdr{max-width:47%}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr:first-of-type{max-width:none;padding-left:20px}}@media only screen and (max-height: 425px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk{height:100%;width:100%;max-width:none}#onetrust-pc-sdk .ot-always-active-group .ot-tgl-cntr{max-width:none}#onetrust-pc-sdk .ot-pc-header{padding:10px;width:calc(100% - 20px)}#onetrust-pc-sdk .ot-lst-cntr{overflow-y:scroll}#onetrust-pc-sdk #ot-lst-cnt{height:auto;overflow:hidden}#onetrust-pc-sdk #accept-recommended-btn-handler{float:right}#onetrust-pc-sdk .save-preference-btn-handler,#onetrust-pc-sdk #accept-recommended-btn-handler,#onetrust-pc-sdk .ot-pc-refuse-all-handler{width:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{height:calc(100% - 155px)}#onetrust-pc-sdk.ot-shw-fltr .ot-lst-cntr{overflow:hidden}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{position:static}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-modal{top:0;width:100%;height:100%;max-height:none}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-modal>div{margin:0;box-sizing:initial;height:100%;max-height:none}#onetrust-pc-sdk.ot-shw-fltr #clear-filters-handler{padding-right:20px}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk .ot-pc-footer button{margin:10px}}@media(max-width: 425px),(max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk .ot-pc-header{padding-right:20px}#onetrust-pc-sdk .ot-pc-logo{margin-left:0px;margin-top:5px;width:150px}#onetrust-pc-sdk .ot-close-icon{width:44px;height:44px;background-size:12px}#onetrust-pc-sdk .ot-grp-hdr1{float:right;margin-left:10px;width:auto}#onetrust-pc-sdk .ot-grp-hdr1{margin-left:0px;padding-right:10px}#onetrust-pc-sdk #ot-pvcy-hdr,#onetrust-pc-sdk .ot-grp-hdr1 .ot-cat-header{display:none}#onetrust-pc-sdk .ot-grp-hdr1+.ot-vlst-cntr{padding-top:10px}}@media only screen and (max-height: 610px){#onetrust-pc-sdk{max-height:100%}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFFFFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler 
                {
                    color: #5D6164;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn
                    {
                        color: #f54632;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { opacity: .7;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk 
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #EA5504;border-color: #EA5504;
                color: #FFFFFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #EA5504;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #78808E; border-color: #78808E;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
            }#onetrust-consent-sdk #onetrust-pc-sdk .category-menu-switch-handler {
                    background-color: #E2E5E6
                }#onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                    background-color: #FFFFFF
                }.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn-apac.onetrust.com/logos/static/ot_persistent_cookie.png')}
                      @keyframes slide-down-custom {
                          0% {
                              bottom: 1080px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      @-webkit-keyframes slide-down-custom {
                          0% {
                              bottom: 1080px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      @-moz-keyframes slide-down-custom {
                          0% {
                              bottom: 1080px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      </style></head>
<body>
<!-- ======================== Header START =================================== -->
<header class="header">
<div class="header-inner">
<div class="logo"><a href="/index.html"><img src="/share/images/logo.png" alt="KYOWA KIRIN"></a></div>
<nav class="header-nav">

<ul class="header-nav-list header-menu">
<li><a href="/index.html">Who we are</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/index.html#anc-in-numbers">In numbers</a></li>
<li><a href="/index.html#anc-our-philosophy">Our philosophy</a></li>
<li><a href="/index.html#anc-core-values">Core values</a></li>
<li><a href="/index.html#anc-at-a-glance">At a glance</a></li>
<li><a href="/index.html#anc-global-network">Global network</a></li>
<li><a href="/index.html#anc-careers">Careers</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/what_we_do/index.html" class="current">What we do</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/what_we_do/index.html#anc-areas-of-focus">Areas of focus</a></li>
<li><a href="/what_we_do/index.html#anc-technology-driven-drug-discovery">Technology-driven drug discovery</a></li>
<li><a href="/what_we_do/index.html#anc-main-products">Main products</a></li>
<li><a href="/what_we_do/index.html#anc-pipeline">Pipeline</a></li>
<li><a href="/what_we_do/index.html#anc-around-the-world">Around the world</a></li>
<li><a href="/what_we_do/index.html#anc-partnerships">Partnerships</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/sustainability/index.html">Sustainability</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/sustainability/index.html#anc-management-philosophy">Management Philosophy and CSV Management</a></li>
<li><a href="/sustainability/index.html#anc-our-approach">Our approach to Sustainability</a></li>
<li><a href="/sustainability/index.html#anc-group-policies">Group Policies</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/stories/index.html">Stories</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/stories/index.html?storiesCategory=patients">Patients</a></li>
<li><a href="/stories/index.html?storiesCategory=innovation">Innovation</a></li>
<li><a href="/stories/index.html?storiesCategory=sustainability">Sustainability</a></li>
<li><a href="/stories/index.html?storiesCategory=people_culture">People &amp; Culture</a></li>
<li><a href="/stories/index.html?storiesCategory=growth">Growth</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/media_center/index.html">Media center</a>
<div class="header-menu-inner">
<ul class="header-list-global">
<li><a href="/media_center/index.html#anc-latest-news">Latest News</a></li>
<li><a href="/media_center/index.html#anc-videos">Videos</a></li>
<!-- /.header-list-global --></ul>

<!-- /.header-menu-inner --></div>
</li>
<li><a href="/careers/index.html">Careers</a></li>
<li><a href="https://ir.kyowakirin.com/en/index.html" target="_blank">Investors<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank"></a></li>
<li>
<div class="box-input-search">
<form name="search_form" action="https://search.kirin.dga.jp/kkc_en/" method="GET" onsubmit="return mysearch_kirin(this,'kkc_en');">
<button type="button" class="header-btn-search"><img src="/share/images/icon_search_01.png" alt="open search area"></button>
<input type="text" name="kw" value="" title="Search" class="iSearchAssist header-input-search searchBox" autocomplete="off">
<input type="hidden" name="ie" value="u">
<input type="submit" class="header-btn-search-submit" value="Search">
<button type="button" class="header-btn-delete"><img src="/share/images/icon_close_02.png" alt="close search area"></button>
</form>

<!-- /.box-input-search --></div>
</li>
<!-- /.header-list --></ul>

<ul class="header-nav-list header-search">
<li class="header-link-contact"><a href="/contact_us/index.html"><img src="/share/images/icon_contact_01.png" alt="move to contact_us page"></a></li>
<li>
<button type="button" class="btn-menu-global" id="menu-global-worldwide">open menu</button>
<div class="menu-global-wrapper">
<h2 class="menu-global-hdg-lv2">Kyowa Kirin Websites Around the World</h2>
<div class="menu-global-inner">

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3-no-toggle">
<a href="/" class="sp-content">Global ( English )</a>
<span class="pc-content">
Global ( <a href="/">English</a> )
<!-- /.pc-content --></span>
<!-- /.menu-global-hdg-lv3-no-toggle --></h3>

<h3 class="menu-global-hdg-lv3">JAPAN<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin Co., Ltd. ( <a href="https://www.kyowakirin.co.jp/index.html" class="text-link-sub" target="_blank"></a> )</li>
<li>FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. ( <a href="http://fujifilmkyowakirin-biologics.com/ja/index.html" class="text-link-sub outBoundModalLink" target="_blank"></a> / <a href="http://fujifilmkyowakirin-biologics.com/en/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin plus Co., Ltd. ( <a href="http://www.kyowakirinplus.co.jp/" class="text-link-sub outBoundModalLink" target="_blank"></a> )</li>
<li>Kyowa Kirin Frontier Co., Ltd. ( <a href="https://www.kyowa-kirin-frontier.com/" class="text-link-sub outBoundModalLink" target="_blank"></a> )</li>
</ul>

<h3 class="menu-global-hdg-lv3">NORTH AMERICA<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin USA Holdings, Inc.  ( <a href="https://kkna.kyowakirin.com/" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>BioWa, Inc.  ( <a href="/biowa/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin, Inc.  ( <a href="https://kkna.kyowakirin.com/" target="_blank" class="text-link-sub outBoundModalLink">English</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3">ASIA PACIFIC<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin Asia Pacific Pte. Ltd.  ( <a href="https://www.kyowakirin.com/asiapacific/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin China Pharmaceutical Co., Ltd.( <a href="https://www.kyowa-kirin.com.cn/" class="text-link-sub outBoundModalLink" target="_blank"></a> / <a href="https://www.kyowa-kirin.com.cn/en/" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin Korea Co., Ltd.  ( <a href="/kr/index.html" class="text-link-sub outBoundModalLink" target="_blank"></a> )</li>
<li>Kyowa Kirin Taiwan Co., Ltd.  ( <a href="/tw/web/#/home" class="text-link-sub outBoundModalLink" target="_blank"></a> )</li>
<li>Kyowa Kirin Hong Kong Co., Limited  ( <a href="/hk/cn/index.html" class="text-link-sub outBoundModalLink" target="_blank"></a> / <a href="/hk/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin (Thailand) Co., Ltd. ( <a href="/thailand/index.html" class="text-link-sub outBoundModalLink" target="_blank"></a> )</li>
<li>Kyowa Kirin Australia Pty Ltd. ( <a href="/australia/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin Malaysia Sdn. Bhd. ( <a href="/malaysia/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<div class="box-list-link">
<h3 class="menu-global-hdg-lv3">EMEA<span class="icon">open</span></h3>
<ul>
<li>Kyowa Kirin International plc  ( <a href="http://www.international.kyowa-kirin.com/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin Ltd.  ( <a href="http://www.international.kyowa-kirin.com/uk/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin Pharma SAS ( <a href="#outBoundModal-exception-02" class="text-link-sub outBoundModalLink">franais</a> )</li>
<li>Kyowa Kirin Farmaceutica, S.L.U.  ( <a href="http://www.international.kyowa-kirin.com/es/index.html" class="text-link-sub outBoundModalLink" target="_blank">Espaol</a> )</li>
<li>Kyowa Kirin GmbH  ( <a href="http://www.international.kyowa-kirin.com/de/index.html" class="text-link-sub outBoundModalLink" target="_blank">Deutsch</a> )</li>
<li>Kyowa Kirin Pharma B.V. - Netherlands  ( <a href="http://www.international.kyowa-kirin.com/nl/index.html" class="text-link-sub outBoundModalLink" target="_blank">Nederlands</a> )</li>
<li>Kyowa Kirin Pharma B.V. - Belgium &amp; Luxembourg  ( <a href="http://international.kyowa-kirin.com/belux/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin S.r.l.  - Italia ( <a href="http://www.international.kyowa-kirin.com/it/index.html" class="text-link-sub outBoundModalLink" target="_blank">Italiano</a> )</li>
<li>Kyowa Kirin AB - Sweden  ( <a href="http://www.international.kyowa-kirin.com/se/index.html" class="text-link-sub outBoundModalLink" target="_blank">Svenska</a> )</li>
<li>Kyowa Kirin AB - Norway  ( <a href="http://www.international.kyowa-kirin.com/no/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin AB - Finland  ( <a href="http://www.international.kyowa-kirin.com/fi/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
<li>Kyowa Kirin AB - Denmark  ( <a href="http://www.international.kyowa-kirin.com/dk/index.html" class="text-link-sub outBoundModalLink" target="_blank">English</a> )</li>
</ul>
<!-- /.box-list-link --></div>

<!-- /.menu-global-inner --></div>
<!-- /.menu-global-wrapper --></div>
</li>
<li>
<button type="button" class="btn-sp-menu"><img src="/share/images/icon_menu_sp_01.png" alt="open menu"></button>
</li>
<!-- /.header-list --></ul>

<ul class="header-nav-list header-menu-sp" style="display: none;">
<li>
<div class="box-input-search">
<form name="search_form" action="https://search.kirin.dga.jp/kkc_en/" method="GET" onsubmit="return mysearch_kirin(this,'kkc_en');">
<button type="button" class="header-btn-search"><img src="/share/images/icon_search_03.png" alt="open search area"></button>
<input type="text" name="kw" value="" title="Search" class="iSearchAssist header-input-search searchBox" autocomplete="off">
<input type="hidden" name="ie" value="u">
<input type="submit" class="header-btn-search-submit" value="Search">
<button type="button" class="header-btn-delete"><img src="/share/images/icon_close_03.png" alt="close search area"></button>
</form>

<!-- /.box-input-search --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">Who we are<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/index.html">Who we are TOP</a>
<ul class="header-menu-sp-list">
<li><a href="/index.html#anc-in-numbers">In numbers</a></li>
<li><a href="/index.html#anc-our-philosophy">Our philosophy</a></li>
<li><a href="/index.html#anc-core-values">Core values</a></li>
<li><a href="/index.html#anc-at-a-glance">At a glance</a></li>
<li><a href="/index.html#anc-global-network">Global network</a></li>
<li><a href="/index.html#anc-careers">Careers</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">What we do<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/what_we_do/index.html">What we do TOP</a>
<ul class="header-menu-sp-list">
<li><a href="/what_we_do/index.html#anc-areas-of-focus">Areas of focus</a></li>
<li><a href="/what_we_do/index.html#anc-technology-driven-drug-discovery">Technology-driven drug discovery</a></li>
<li><a href="/what_we_do/index.html#anc-main-products">Main products</a></li>
<li><a href="/what_we_do/index.html#anc-pipeline">Pipeline</a></li>
<li><a href="/what_we_do/index.html#anc-around-the-world">Around the world</a></li>
<li><a href="/what_we_do/index.html#anc-partnerships">Partnerships</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">Sustainability<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/sustainability/index.html">Sustainability TOP</a>
<ul class="header-menu-sp-list">
<li><a href="/sustainability/index.html#anc-management-philosophy">Management Philosophy and CSV Management</a></li>
<li><a href="/sustainability/index.html#anc-our-approach">Our approach to Sustainability</a></li>
<li><a href="/sustainability/index.html#anc-group-policies">Group Policies</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">Stories<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/stories/index.html">Stories TOP</a>
<ul class="header-menu-sp-list">
<li><a href="/stories/index.html?storiesCategory=patients">Patients</a></li>
<li><a href="/stories/index.html?storiesCategory=innovation">Innovation</a></li>
<li><a href="/stories/index.html?storiesCategory=sustainability">Sustainability</a></li>
<li><a href="/stories/index.html?storiesCategory=people_culture">People &amp; Culture</a></li>
<li><a href="/stories/index.html?storiesCategory=growth">Growth</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><button type="button" class="btn-header-menu-sp-toggle">Media center<span>open</span></button>
<div class="header-menu-sp-toggle">
<a href="/media_center/index.html">Media center TOP</a>
<ul class="header-menu-sp-list">
<li><a href="/media_center/index.html#anc-latest-news">Latest News</a></li>
<li><a href="/media_center/index.html#anc-videos">Videos</a></li>
</ul>
<!-- /.header-menu-sp-list --></div>
</li>
<li><a href="/careers/index.html">Careers</a></li>
<li><a href="https://ir.kyowakirin.com/en/index.html" target="_blank"><span class="type-03">Investors<img src="/share/images/icon_link_blank_03.png" alt="Open in new window" class="icon-blank"></span></a></li>
<!-- /.header-list --></ul>

<!-- /.header-nav --></nav>
<!-- /.header-inner --></div>
</header>
<!-- ======================== Header END =================================== -->

<main>
<!-- ======================== Main Content START =================================== -->
<div class="wrapper">

<div class="box-hdg-wrapper type-02 kkc-anime_load_other-mainvisual">
<h1 class="hdg-lv1-01">What we do<span class="text-sub">State-of-the-art biotechnology<br>
centered on antibody engineering</span></h1>
<div class="image">
<img src="/what_we_do/images/index_img_hdg_01.jpg" alt="" class="sp-hide">
<img src="/what_we_do/images/index_img_hdg_01_sp.jpg" alt="" class="pc-hide">
<!-- /.image --></div>
<!-- /.box-hdg-wrapper --></div>

<div class="str-section-wrapper whatwedo-01">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-areas-of-focus">
<h2 class="hdg-lv2-02">Areas of focus</h2>
<p class="text-lead">Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to <br>human health and well-being worldwide through innovative drug discovery and <br>global commercialization, driven by state-of-the-art antibody technologies, <br>in the core therapeutic areas of oncology, nephrology, <br>central nervous system and immunology.</p>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>

<div class="area-focus-wrapper">
<div class="area-focus-inner">
<p class="title">Cutting-edge biotechnology<br> centered on antibody<br> engineering technology</p>
<!-- /.area-focus-inner --></div>
<div class="area-focus-icon icon-01 kkc-anime_scroll_focus-icon_trigger kkc-anime_trigger_focus-icon_item kkc-anime_state_show kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger="focus-icon1" data-trigger-name="focus-icon1">
<img src="/what_we_do/images/index_img_parts_01.png" class="sp-hide" alt="Nephrology">
<img src="/what_we_do/images/index_img_parts_01_sp.png" class="pc-hide" alt="Nephrology">
</div>
<div class="area-focus-icon icon-02 kkc-anime_trigger_focus-icon_item kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger-name="focus-icon1">
<img src="/what_we_do/images/index_img_parts_02.png" class="sp-hide" alt="Immunology &amp; Allergy">
<img src="/what_we_do/images/index_img_parts_02_sp.png" class="pc-hide" alt="Immunology &amp; Allergy">
</div>
<div class="area-focus-icon icon-03 kkc-anime_scroll_focus-icon_trigger kkc-anime_trigger_focus-icon_item kkc-anime_state_show kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger="focus-icon2" data-trigger-name="focus-icon2">
<img src="/what_we_do/images/index_img_parts_03.png" class="sp-hide" alt="Oncology">
<img src="/what_we_do/images/index_img_parts_03_sp.png" class="pc-hide" alt="Oncology">
</div>
<div class="area-focus-icon icon-04 kkc-anime_trigger_focus-icon_item kkc-anime_state_ignition kkc-anime_state_animation-end" data-trigger-name="focus-icon2">
<img src="/what_we_do/images/index_img_parts_04.png" class="sp-hide" alt="Central Nervous System">
<img src="/what_we_do/images/index_img_parts_04_sp.png" class="pc-hide" alt="Central Nervous System">
</div>
<!-- /.area-focus-wrapper --></div>

<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper type-01 whatwedo-02">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-technology-driven-drug-discovery">
<h2 class="hdg-lv2-02">Technology-driven drug discovery</h2>
<p class="text-lead">The novel drug discovery of Kyowa Kirin is firmly<br class="pc-hide"> supported by the exquisite experience and<br>
technologies in research, development and<br class="pc-hide"> manufacture of biologics, and by open<br class="pc-hide"> innovation.<br class="sp-hide">
This unique style of drug discovery is<br class="pc-hide"> what we call technology-driven drug discovery,<br class="pc-hide"> focused<br class="sp-hide"> on the key technologies below.</p>
<!-- /.box-hdg2-wrapper --></div>

<div class="box-panel-01 col4 sp-col2">

<a href="/what_we_do/approach_for_innovation/index.html#anc-h5o-3" class="panel">
<div class="box-inner">
<div class="box-content">
<h3 class="title">Next Generation<br> Therapeutic Antibodies</h3>
<p class="link-arrow"><span>LEARN MORE</span></p>
<!-- /.box-content --></div>
<div class="box-image"><img src="/what_we_do/images/index_img_01.jpg" alt=""></div>
<!-- /.box-inner--></div>
<!-- /.panel --></a>

<a href="/what_we_do/approach_for_innovation/index.html#anc-h5o-4" class="panel">
<div class="box-inner">
<div class="box-content">
<h3 class="title">New Type of Small<br> Molecule Drugs</h3>
<p class="link-arrow"><span>LEARN MORE</span></p>
<!-- /.box-content --></div>
<div class="box-image"><img src="/what_we_do/images/index_img_02.jpg" alt=""></div>
<!-- /.box-inner--></div>
<!-- /.panel --></a>

<a href="/what_we_do/approach_for_innovation/index.html#anc-h5o-5" class="panel">
<div class="box-inner">
<div class="box-content">
<h3 class="title">Nucleic Acid Drugs</h3>
<p class="link-arrow"><span>LEARN MORE</span></p>
<!-- /.box-content --></div>
<div class="box-image"><img src="/what_we_do/images/index_img_03.jpg" alt=""></div>
<!-- /.box-inner--></div>
<!-- /.panel --></a>

<a href="/what_we_do/approach_for_innovation/index.html#anc-h5o-6" class="panel">
<div class="box-inner">
<div class="box-content">
<h3 class="title">Regenerative Medicine</h3>
<p class="link-arrow"><span>LEARN MORE</span></p>
<!-- /.box-content --></div>
<div class="box-image"><img src="/what_we_do/images/index_img_04.jpg" alt=""></div>
<!-- /.box-inner--></div>
<!-- /.panel --></a>

<!-- /.box-panel-01 --></div>

<!-- /.str-section --></div>
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper whatwedo-03">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-main-products">
<h2 class="hdg-lv2-02">Main products</h2>
<!-- /.box-hdg2-wrapper --></div>

<!-- /.str-section --></div>

<div class="box-carousel-wrapper">
<div class="box-carousel-01 slick-initialized slick-slider"><button class="slick-prev slick-arrow" aria-label="Previous" type="button" style="">Previous</button>
<div class="slick-list draggable"><div class="slick-track" style="opacity: 1; width: 3920px; transform: translate3d(-980px, 0px, 0px);"><a href="/what_we_do/products/regpara/index.html" class="panel slick-slide slick-cloned" data-slick-index="-4" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_regpara.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">REGPARA<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/nourianz/index.html" class="panel slick-slide slick-cloned" data-slick-index="-3" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_nourianz.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">Nouriast<sup></sup>/ Nourianz<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/espo_nesp/index.html" class="panel slick-slide slick-cloned" data-slick-index="-2" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_espo.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">ESPO<sup></sup>&nbsp;/ NESP<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/gran_peglasta_neulasta/index.html" class="panel slick-slide slick-cloned" data-slick-index="-1" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_gran.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">GRAN<sup></sup> / Peglasta<sup></sup> / Neulasta<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/crysvita/index.html" class="panel slick-slide slick-current slick-active" data-slick-index="0" aria-hidden="false" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_crysvita.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">Crysvita<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/poteligeo/index.html" class="panel slick-slide slick-active" data-slick-index="1" aria-hidden="false" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_poteligeo.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">POTELIGEO<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/regpara/index.html" class="panel slick-slide slick-active" data-slick-index="2" aria-hidden="false" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_regpara.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">REGPARA<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/nourianz/index.html" class="panel slick-slide slick-active" data-slick-index="3" aria-hidden="false" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_nourianz.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">Nouriast<sup></sup>/ Nourianz<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/espo_nesp/index.html" class="panel slick-slide" data-slick-index="4" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_espo.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">ESPO<sup></sup>&nbsp;/ NESP<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/gran_peglasta_neulasta/index.html" class="panel slick-slide" data-slick-index="5" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_gran.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">GRAN<sup></sup> / Peglasta<sup></sup> / Neulasta<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/crysvita/index.html" class="panel slick-slide slick-cloned" data-slick-index="6" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_crysvita.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">Crysvita<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/poteligeo/index.html" class="panel slick-slide slick-cloned" data-slick-index="7" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_poteligeo.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">POTELIGEO<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/regpara/index.html" class="panel slick-slide slick-cloned" data-slick-index="8" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_regpara.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">REGPARA<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/nourianz/index.html" class="panel slick-slide slick-cloned" data-slick-index="9" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_nourianz.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">Nouriast<sup></sup>/ Nourianz<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/espo_nesp/index.html" class="panel slick-slide slick-cloned" data-slick-index="10" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_espo.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">ESPO<sup></sup>&nbsp;/ NESP<sup></sup></h3>
<!-- /.panel --></a><a href="/what_we_do/products/gran_peglasta_neulasta/index.html" class="panel slick-slide slick-cloned" data-slick-index="11" aria-hidden="true" style="width: 225px;">
<div class="panel-image"><div class="panel-image-inr"><img src="/what_we_do/images/index_img_slide_gran.jpg" alt=""></div></div>
<h3 class="hdg-lv3-01 type-01">GRAN<sup></sup> / Peglasta<sup></sup> / Neulasta<sup></sup></h3>
<!-- /.panel --></a></div></div>










<!-- /.box-carousel-01 --><button class="slick-next slick-arrow" aria-label="Next" type="button" style="">Next</button></div>
<!-- /.box-carousel-wrapper --></div>

<div class="box-layout-btn btn-center" data-column-sp="0">
<a href="/what_we_do/products/index.html" class="btn-03">See list of products</a>
<!-- /.box-layout-btn --></div>

<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper type-01 whatwedo-04">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-pipeline">
<h2 class="hdg-lv2-02">Pipeline</h2>
<p class="text-lead">Numerous promising pharmaceutical<br class="pc-hide"> candidates are emerging from our<br class="pc-hide"> development pipelines.<br class="sp-hide"> They are the result of our<br class="pc-hide"> never-ending efforts in honing the edge of our<br class="pc-hide"> state-of-the-art<br class="sp-hide"> technologies and deliver<br class="pc-hide"> innovation in medical care.</p>
<!-- /.box-hdg2-wrapper --></div>

<!-- /.str-section --></div>

<div class="pipeline-table-wrapper">
<button class="pipeline-btn-accordion" aria-expanded="false" aria-controls="pipeline-table-content" type="button">SEE FULL LIST</button>
<div id="pipeline-table-content" class="pipeline-table-content" aria-hidden="true">
<p class="pipeline-hdg-pdf"><a href="/what_we_do/pdf/pipeline_e20220630.pdf" target="_blank" class="sizeAdded"><span>As of June 30, 2022</span><span class="pdf-text"><img src="/share/images/icon_pdf_blank_10.png" alt="PDF file">Kyowa Kirin R&amp;D Pipeline</span> (466KB)</a></p>

<div class="box-tab-01">
<ul class="list-tab">
<li><a href="#tab-1" class="current">Overview</a></li>
<li><a href="#tab-2">Recent Changes</a></li>
<!-- /.list-tab --></ul>

<div class="box-tab-content" id="tab-1" style="display: block;">
<div class="pipeline-box-search">
<button class="pipeline-btn-accordion _search" type="button" aria-expanded="true" aria-hidden="true" aria-controls="pipeline-box-search-inner">Search</button>
<div id="pipeline-box-search-inner" class="inner" aria-hidden="false">
<div class="content">
<div class="title">Modalities :</div>
<ul class="list">
<li><label class="pipeline-checkbox"><input type="checkbox" name="modalities" class="item" value="00"><span>ALL</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="modalities" class="item" value="01"><span>antibody</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="modalities" class="item" value="02"><span>protein</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="modalities" class="item" value="03"><span>small molecule</span></label></li>
</ul>
</div>
<div class="content">
<div class="title">Therapeutic Area :</div>
<ul class="list">
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="00"><span>ALL</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="01"><span><img src="/what_we_do/images/index_icon_nephrology.png" alt="" width="22" height="20">Nephrology</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="02"><span><img src="/what_we_do/images/index_icon_oncology.png" alt="" width="22" height="22">Oncology</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="03"><span><img src="/what_we_do/images/index_icon_immunology-allergy.png" alt="" width="22" height="20">Immunology/Allergy</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="04"><span><img src="/what_we_do/images/index_icon_central-nervous-system.png" alt="" width="22" height="19">Central Nervous System</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="therapeuticArea" class="item" value="05"><span><img src="/what_we_do/images/index_icon_other.png" alt="" width="15" height="24">Other</span></label></li>
</ul>
</div>
<div class="content">
<div class="title">Region :</div>
<ul class="list">
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="00"><span>ALL</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="01"><span>Japan</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="02"><span>North America</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="03"><span>EMEA</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="04"><span>Asia Pacific</span></label></li>
<li><label class="pipeline-checkbox"><input type="checkbox" name="regionCategory" class="item" value="05"><span>Other</span></label></li>
</ul>
</div>
</div>
</div>

<div class="pipeline-table" data-mount-name="overview">
<div class="inner">
<ul class="head sticky">
<li class="item codeName">
<button class="desc" type="button"><span>Code Name</span></button>
<!-- /.item.product --></li>
<li class="item genericName">
<p>Generic name</p>
<!-- /.item.treatment --></li>
<li class="item therapeuticArea">
<p>Therapeutic Area</p>
<!-- /.item.disease --></li>
<li class="item indication">
<p>Indication</p>
<!-- /.item.disease --></li>
<li class="item phase">
<button class="desc" type="button"><span>Phase</span></button>
<ul class="phaseList">
<li class="item">1</li>
<li class="item">2</li>
<li class="item">3</li>
<li class="item">F</li>
<li class="item">A</li>
</ul>
<!-- /.item.phase --></li>
<li class="item region">
<p>Region</p>
<!-- /.item.region --></li>
<!-- /.head --></ul>
<ul class="content">
<!-- /.content --><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_0"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Treatment of Aplastic Anemia (AA) Which Is Refractory to Immunosuppressive Therapy or AA not Amenable to Immunosuppressive Therapy</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>SG</p></li></ul><dl id="contentList737096_0" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_1"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP) Who Do Not Respond Well to Other Treatments, Such as Corticosteroids and Immunoglobulin</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>CN</p></li></ul><dl id="contentList737096_1" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_2"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Ankylosing Spondylitis</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>TW</p></li></ul><dl id="contentList737096_2" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_3"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KRN125</p></li><li class="item genericName"><p>Pegfilgrastim</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Allogeneic Blood Stem Cell Transplantation</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_3" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Pegfilgrastim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Long-Acting Granulocyte Colony-Stimulating Factor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_4"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KRN23</p></li><li class="item genericName"><p>Burosumab</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>X-linked<br>Hypophosphatemia (XLH)</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>TH</p></li></ul><dl id="contentList737096_4" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Burosumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-FGF23 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Human Antibody-Producing Technology<br>Jointly Developed with Ultragenyx in US and EU</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_5"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KW-0761</p></li><li class="item genericName"><p>Mogamulizumab</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mycosis Fungoides and Szary Syndrome</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>CA</p></li></ul><dl id="contentList737096_5" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Mogamulizumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-CCR4 Humanized Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_6"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Treatment of Aplastic Anemia (AA) Which Is Refractory to Immunosuppressive Therapy or AA not Amenable to Immunosuppressive Therapy</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>MY and TH</p></li></ul><dl id="contentList737096_6" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_7"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Systemic Sclerosis</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_7" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03957681</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_8"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Ankylosing Spondylitis</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>MY and TH</p></li></ul><dl id="contentList737096_8" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_9"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Non-radiographic Axial Spondyloarthritis</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>TH</p></li></ul><dl id="contentList737096_9" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_10"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KRN125</p></li><li class="item genericName"><p>Pegfilgrastim</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Automated Injection Device for Decreasing the Incidence of Febrile Neutropenia in Patients Receiving Cancer Chemotherapy</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_10" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Pegfilgrastim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Long-Acting Granulocyte Colony-Stimulating Factor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_11"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KRN23</p></li><li class="item genericName"><p>Burosumab</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>X-linked<br>Hypophosphatemia (XLH)</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>MY</p></li></ul><dl id="contentList737096_11" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Burosumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-FGF23 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Human Antibody-Producing Technology<br>Jointly Developed with Ultragenyx in US and EU</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_12"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KRN23</p></li><li class="item genericName"><p>Burosumab</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Tumor Induced Osteomalacia(TIO)</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>Europe</p></li></ul><dl id="contentList737096_12" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Burosumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-FGF23 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Human Antibody-Producing Technology<br>Jointly Developed with Ultragenyx in US and EU</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_13"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KW-0761</p></li><li class="item genericName"><p>Mogamulizumab</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mycosis Fungoides and Szary Syndrome</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>KR, KW, CN, AE and IL</p></li></ul><dl id="contentList737096_13" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Mogamulizumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-CCR4 Humanized Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_14"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">RTA 402</p></li><li class="item genericName"><p>Bardoxolone Methyl</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Alport Syndrome</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_14" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Bardoxolone Methyl</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Antioxidant Inflammation Modulator</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Reata</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_15"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Aplastic Anemia Who Were Previously Untreated with Immunosuppressive Therapy</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP and Asia</p></li></ul><dl id="contentList737096_15" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03957694, NCT04095936</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_16"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4083/AMG 451</p></li><li class="item genericName"><p>Rocatinlimab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Atopic Dermatitis</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP, NA and Europe</p></li></ul><dl id="contentList737096_16" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Rocatinlimab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-OX40 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT<br>Human Antibody-Producing Technology<br>Collaboration agreement with Amgen for the development of KHK4083/AMG 451 in all the countries except for Japan.</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03703102</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_17"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Palmoplantar Pustulosis</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_17" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04061252</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_18"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">KHK7580</p></li><li class="item genericName"><p>Evocalcet</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Secondary Hyperparathyroidism</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>CN and Asia</p></li></ul><dl id="contentList737096_18" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Evocalcet</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Calcimimetic</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Mitsubishi Tanabe Pharma</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03822507</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_19"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">KHK7791</p></li><li class="item genericName"><p>Tenapanor Hydrochloride</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Hyperphosphatemia in Patients on Dialysis</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_19" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Tenapanor Hydrochloride</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>NHE3 inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Ardelyx</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04771780, NCT04766385, NCT04767581, NCT04766398</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_20"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">KW-3357</p></li><li class="item genericName"><p>Antithrombin Gamma</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Preeclampsia</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_20" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Antithrombin Gamma</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Recombinant Human Antithrombin</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04182373</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_21"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">ME-401</p></li><li class="item genericName"><p>Zandelisib</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Follicular Lymphoma and Marginal Zone Lymphoma</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP, NA, Europe, Asia, Oceania and others</p></li></ul><dl id="contentList737096_21" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Zandelisib</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>PI3K inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>MEI Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Combination with rituximab, Second line +</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04745832</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_22"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">RTA 402</p></li><li class="item genericName"><p>Bardoxolone Methyl</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Diabetic Kidney Disease</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_22" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Bardoxolone Methyl</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Antioxidant Inflammation Modulator</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Reata</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03550443</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_23"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_nephrology.png" alt="">RTA 402</p></li><li class="item genericName"><p>Bardoxolone Methyl</p></li><li class="item therapeuticArea"><p>Nephrology</p></li><li class="item indication"><p>Autosomal Dominant Polycystic Kidney Disease</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_23" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Bardoxolone Methyl</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Antioxidant Inflammation Modulator</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Reata</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03918447</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_24"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KRN125</p></li><li class="item genericName"><p>Pegfilgrastim</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Blood Stem Cell Transplantation</p></li><li class="item phase"><ul class="phaseList" data-phase="2"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_24" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Pegfilgrastim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Long-Acting Granulocyte Colony-Stimulating Factor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT05007652</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_25"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_central-nervous-system.png" alt="">KW-6356</p></li><li class="item genericName"><p>-</p></li><li class="item therapeuticArea"><p>Central Nervous System</p></li><li class="item indication"><p>Parkinson's Disease</p></li><li class="item phase"><ul class="phaseList" data-phase="2"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_25" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>-</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Adenosine A2A Receptor Antagonist/Inverse Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT02939391, NCT03703570</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_26"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">ME-401</p></li><li class="item genericName"><p>Zandelisib</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Follicular Lymphoma</p></li><li class="item phase"><ul class="phaseList" data-phase="2"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>NA, Europe, Asia and Oceania</p></li></ul><dl id="contentList737096_26" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Zandelisib</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>PI3K inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>MEI Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Third line +</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03768505</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_27"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">ME-401</p></li><li class="item genericName"><p>Zandelisib</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Marginal Zone Lymphoma</p></li><li class="item phase"><ul class="phaseList" data-phase="2"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>NA, Europe, Asia and Oceania</p></li></ul><dl id="contentList737096_27" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Zandelisib</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>PI3K inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>MEI Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Third line +</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03768505</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_28"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">ME-401</p></li><li class="item genericName"><p>Zandelisib</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Indolent B-cell Non-Hodgkin's Lymphoma</p></li><li class="item phase"><ul class="phaseList" data-phase="2"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_28" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Zandelisib</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>PI3K inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>MEI Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Third line +</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04533581, NCT03985189Pin Japan</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_29"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KHK4951</p></li><li class="item genericName"><p>-</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Wet Age-Related Macular Degeneration</p></li><li class="item phase"><ul class="phaseList" data-phase="1"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="true"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList737096_29" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>-</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Ophthalmic</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT04594681</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_30"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_central-nervous-system.png" alt="">KHK6640</p></li><li class="item genericName"><p>-</p></li><li class="item therapeuticArea"><p>Central Nervous System</p></li><li class="item indication"><p>Alzheimer's Disease</p></li><li class="item phase"><ul class="phaseList" data-phase="1"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="true"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP and Europe</p></li></ul><dl id="contentList737096_30" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>-</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-Amyloid Beta Peptide Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Immunas Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT02127476, NCT03093519, NCT02377713</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_31"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KW-3357</p></li><li class="item genericName"><p>Antithrombin Gamma</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Disseminated<br>Intravascular Coagulation,<br>Congenital Antithrombin<br>Deficiency</p></li><li class="item phase"><ul class="phaseList" data-phase="1"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="true"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>Europe</p></li></ul><dl id="contentList737096_31" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Antithrombin Gamma</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Recombinant Human Antithrombin</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT00938288</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList737096_32"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">ME-401</p></li><li class="item genericName"><p>Zandelisib</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>B-cell malignancies</p></li><li class="item phase"><ul class="phaseList" data-phase="1"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="true"><p>2</p></li><li class="item" aria-hidden="true"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>NA</p></li></ul><dl id="contentList737096_32" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Zandelisib</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Oral</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>PI3K inhibitor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>MEI Pharma</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Monotherapy, combination with rituximab and combination with zanubrutinib</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT02914938</dd></div></dl></li></ul>
<!-- /.inner --></div>
<!-- /.pipeline-table --></div>

<!-- /.box-tab-content --></div>

<div class="box-tab-content" id="tab-2">
<div class="pipeline-box-hdg-wrapper">
<h3 class="hdg-lv3-01">New / Advanced</h3>
<p class="pipeline-text-date">Since December 31, 2021</p>
</div>

<div class="pipeline-table" data-mount-name="recentChanges1">
<div class="inner">
<ul class="head sticky">
<li class="item codeName">
<span>Code Name</span>
<!-- /.item.product --></li>
<li class="item genericName">
<p>Generic name</p>
<!-- /.item.treatment --></li>
<li class="item therapeuticArea">
<p>Therapeutic Area</p>
<!-- /.item.disease --></li>
<li class="item indication">
<p>Indication</p>
<!-- /.item.disease --></li>
<li class="item phase">
<span>Phase</span>
<ul class="phaseList">
<li class="item">1</li>
<li class="item">2</li>
<li class="item">3</li>
<li class="item">F</li>
<li class="item">A</li>
</ul>
<!-- /.item.phase --></li>
<li class="item region">
<p>Region</p>
<!-- /.item.region --></li>
<!-- /.head --></ul>
<ul class="content">
<!-- /.content --><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_0"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Treatment of Aplastic Anemia (AA) Which Is Refractory to Immunosuppressive Therapy or AA not Amenable to Immunosuppressive Therapy</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>SG</p></li></ul><dl id="contentList393245_0" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_1"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">AMG531</p></li><li class="item genericName"><p>Romiplostim</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP) Who Do Not Respond Well to Other Treatments, Such as Corticosteroids and Immunoglobulin</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>CN</p></li></ul><dl id="contentList393245_1" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Romiplostim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Thrombopoietin Receptor Agonist</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_2"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4827</p></li><li class="item genericName"><p>Brodalumab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Ankylosing Spondylitis</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>TW</p></li></ul><dl id="contentList393245_2" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Brodalumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-IL-17 Receptor A Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_3"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KRN125</p></li><li class="item genericName"><p>Pegfilgrastim</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Allogeneic Blood Stem Cell Transplantation</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>JP</p></li></ul><dl id="contentList393245_3" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Pegfilgrastim</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Long-Acting Granulocyte Colony-Stimulating Factor</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>Amgen K-A</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_4"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_other.png" alt="">KRN23</p></li><li class="item genericName"><p>Burosumab</p></li><li class="item therapeuticArea"><p>Other</p></li><li class="item indication"><p>X-linked<br>Hypophosphatemia (XLH)</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>TH</p></li></ul><dl id="contentList393245_4" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Burosumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-FGF23 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>Human Antibody-Producing Technology<br>Jointly Developed with Ultragenyx in US and EU</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_5"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KW-0761</p></li><li class="item genericName"><p>Mogamulizumab</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mycosis Fungoides and Szary Syndrome</p></li><li class="item phase"><ul class="phaseList" data-phase="5"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="false"><p>A</p></li></ul></li><li class="item region"><p>CA</p></li></ul><dl id="contentList393245_5" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Mogamulizumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-CCR4 Humanized Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_6"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_oncology.png" alt="">KW-0761</p></li><li class="item genericName"><p>Mogamulizumab</p></li><li class="item therapeuticArea"><p>Oncology</p></li><li class="item indication"><p>Mycosis Fungoides and Szary Syndrome</p></li><li class="item phase"><ul class="phaseList" data-phase="4"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="false"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>AE and IL</p></li></ul><dl id="contentList393245_6" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Mogamulizumab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-CCR4 Humanized Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT</dd></div></dl></li><li class="contentList"><ul class="itemList _body" tabindex="0" aria-expanded="false" aria-controls="contentList393245_7"><li class="item codeName"><p><img class="mr-10" src="/what_we_do/images/index_icon_immunology-allergy.png" alt="">KHK4083/AMG 451</p></li><li class="item genericName"><p>Rocatinlimab</p></li><li class="item therapeuticArea"><p>Immunology/Allergy</p></li><li class="item indication"><p>Atopic Dermatitis</p></li><li class="item phase"><ul class="phaseList" data-phase="3"><li class="item" aria-hidden="false"><p>1</p></li><li class="item" aria-hidden="false"><p>2</p></li><li class="item" aria-hidden="false"><p>3</p></li><li class="item" aria-hidden="true"><p>F</p></li><li class="item" aria-hidden="true"><p>A</p></li></ul></li><li class="item region"><p>JP, NA and Europe</p></li></ul><dl id="contentList393245_7" class="itemList _detail" aria-hidden="true"><div class="item genericName"><dt>Generic name : </dt><dd>Rocatinlimab</dd></div><div class="item formulation"><dt>Formulation : </dt><dd>Injection</dd></div><div class="item mechanismOfAction"><dt>Mechanism of Action : </dt><dd>Anti-OX40 Fully Human Antibody</dd></div><div class="item inHouseOrLicensed"><dt>In-House or Licensed : </dt><dd>In-House</dd></div><div class="item projectType"><dt>Project Type : </dt><dd>New Molecular Entity</dd></div><div class="item remarks"><dt>Remarks : </dt><dd>POTELLIGENT<br>Human Antibody-Producing Technology<br>Collaboration agreement with Amgen for the development of KHK4083/AMG 451 in all the countries except for Japan.</dd></div><div class="item clinicalTrialInformation"><dt>Clinical Trial Infomation : </dt><dd>NCT03703102</dd></div></dl></li></ul>
<!-- /.inner --></div>
<!-- /.pipeline-table --></div>

<!--
<div class="pipeline-box-hdg-wrapper mt-30">
<h3 class="hdg-lv3-01">Removed</h3>
</div>
-->

<div class="pipeline-table pc-hide sp-hide" data-mount-name="recentChanges2">
<div class="inner">
<ul class="head sticky">
<li class="item codeName">
<span>Code Name</span>
<!-- /.item.product --></li>
<li class="item genericName">
<p>Generic name</p>
<!-- /.item.treatment --></li>
<li class="item therapeuticArea">
<p>Therapeutic Area</p>
<!-- /.item.disease --></li>
<li class="item indication">
<p>Indication</p>
<!-- /.item.disease --></li>
<li class="item phase">
<span>Phase</span>
<ul class="phaseList">
<li class="item">1</li>
<li class="item">2</li>
<li class="item">3</li>
<li class="item">F</li>
<li class="item">A</li>
</ul>
<!-- /.item.phase --></li>
<li class="item region">
<p>Region</p>
<!-- /.item.region --></li>
<!-- /.head --></ul>
<ul class="content">
<!-- /.content --></ul>
<!-- /.inner --></div>
<!-- /.pipeline-table --></div>

<!-- /.box-tab-content --></div>

<!-- /.box-tab-01 --></div>
<!-- /.pipeline-table-content --></div>
<noscript>
<div class="box-01">
<p>This website uses JavaScript to display a part of contents.</p>
<p>Please enable JavaScript in your browser to correctly veiw our website.</p>
<!-- /.box-01 --></div>
</noscript>
<!-- /.pipeline-table-wrapper --></div>
<div class="str-section">
<ul class="list-notice-01">
<li><div class="symbol"></div><div>Since the development of KHK2455 for solid tumor and urothelial carcinoma was discontinued, the relevant information was deleted from this table.</div></li>
<li><div class="symbol"></div><div>We decided to discontinue the development of KW-6356 in the central nervous system field in July.</div></li>
</ul>
<!-- /.str-section --></div>
<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper whatwedo-05">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-around-the-world">
<h2 class="hdg-lv2-02">Around the world</h2>
<p class="text-lead">Seamless collaboration between regions<br class="pc-hide"> ensures timely<br class="sp-hide"> delivery of novel medicines<br class="pc-hide"> to patients around the world,<br class="sp-hide"> enhanced by<br class="pc-hide"> close ties to research partners.</p>
<!-- /.box-hdg2-wrapper --></div>
<!-- /.str-section --></div>

<div class="global-base-wrapper">
<div class="global-base-inner">
<ul class="list-global-base col3">
<li class="col kkc-anime_scroll_common_fade-in-bottom">
<a href="https://www.kyowakirin.co.jp/index.html" target="_blank" class="panel">
<div class="box-thumb"><img src="/what_we_do/images/index_img_05.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Kyowa Kirin Co., Ltd. (HQ)<span class="sub">JAPAN</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom">
<a href="/what_we_do/research_laboratories/index.html#anc-cmc" class="panel">
<div class="box-thumb"><img src="/what_we_do/images/index_img_06.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">CMC R&amp;D Center<span class="sub">JAPAN</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom">
<a href="http://www.international.kyowa-kirin.com/index.html" target="_blank" class="panel outBoundModalLink">
<div class="box-thumb"><img src="/what_we_do/images/index_img_07.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Kyowa Kirin International plc<span class="sub">UK</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="/what_we_do/research_laboratories/index.html#anc-tokyo-research-park" class="panel">
<div class="box-thumb"><img src="/what_we_do/images/index_img_08.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Tokyo Research Park<span class="sub">JAPAN</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="https://www.kyowa-kirin.com.cn/" target="_blank" class="panel outBoundModalLink">
<div class="box-thumb"><img src="/what_we_do/images/index_img_10.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Kyowa Kirin China Pharmaceutical Co., Ltd.<span class="sub">CHINA</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="/what_we_do/research_laboratories/index.html#anc-fuji-research-park" class="panel">
<div class="box-thumb"><img src="/what_we_do/images/index_img_11.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Fuji Research Park<span class="sub">JAPAN</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="https://kkna.kyowakirin.com/" target="_blank" class="panel outBoundModalLink">
<div class="box-thumb"><img src="/what_we_do/images/index_img_09.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Kyowa Kirin, Inc.<span class="sub">USA</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="/kr/index.html" target="_blank" class="panel outBoundModalLink">
<div class="box-thumb"><img src="/what_we_do/images/index_img_13.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Kyowa Kirin Korea Co., Ltd.<span class="sub">KOREA</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<li class="col kkc-anime_scroll_common_fade-in-bottom js-hide">
<a href="/what_we_do/research_laboratories/index.html#anc-bio-process-research" class="panel">
<div class="box-thumb"><img src="/what_we_do/images/index_img_14.jpg" alt=""></div>
<div class="box-content">
<h3 class="title">Bio Process Research and Development Laboratories<span class="sub">JAPAN</span></h3>
<img src="/share/images/icon_link_blank_07.png" alt="Open in new window" class="icon-blank">
</div>
<!-- /.panel --></a>
</li>
<!-- /.list-global-base --></ul>
<button type="button" class="btn-more mt-50" style="display: none;">SHOW MORE<span class="status">OPEN</span></button>
<!-- /.global-base-inner --></div>
<!-- /.global-base-wrapper --></div>

<!-- /.str-section-wrapper --></div>

<div class="str-section-wrapper whatwedo-06">
<div class="str-section">

<div class="box-hdg2-wrapper" id="anc-partnerships">
<h2 class="hdg-lv2-02">Partnerships</h2>
<p class="text-lead">We are open and flexible to strategic collaborations<br class="pc-hide"> and partnerships<br class="sp-hide"> with pharmaceuticals, biotech,<br class="pc-hide"> and academia partners.</p>
<!-- /.box-hdg2-wrapper --></div>

<div class="box-text">
<p class="align-c"><a href="/what_we_do/research_collaboration_licensing/index.html" class="link-arrow"><span>LEARN MORE</span></a></p>
<!-- /.box-text --></div>

<div class="box-image">
<img src="/what_we_do/images/index_img_logo_01.jpg" class="sp-hide" alt="ADARE pharmaceuticals Allakos genomic medicine Alnylam PHARMACEUTICALS AMGEN ardelyx AM Pharma ardelyxargenx astellas Leading Light for Life AstraZeneca Medlmmune avalo THERAPEUTICS AVEO ONCOLOGY Biogen BORYUNG Pharmaceutical Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CHUGAI Roche A member of the Roche group Daiichi-Sankyo Dexa Medica Expertise for the Promotion of health Eisai first PHARMACEUTICAL FivePrime FOBENI FUJIFILM Genentech IN BUSINESS FOR LIFE gsk HELSINN Building quality cancer care together Hisamitsu Humanigen IDC Theranostics Immunas Pharma inibsa HOSPITAL INTAS janssen JB Japan Blood Products Organization Jazz Pharmaceuticals LEO Lonza MEI pharma meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Solasia Synaffix Syndax synmosa Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion TOYOCHEM ultragenyx pharmaceutical Winhealth Pharma WIDATRA ZUELLIG PHARMA making healthcare more accessible">
<img src="/what_we_do/images/index_img_logo_01_sp.jpg" class="pc-hide" alt="ADARE pharmaceuticals Allakos genomic medicine Alnylam PHARMACEUTICALS AMGEN ardelyx AM Pharma ardelyxargenx astellas Leading Light for Life AstraZeneca Medlmmune avalo THERAPEUTICS AVEO ONCOLOGY Biogen BORYUNG Pharmaceutical Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CHUGAI Roche A member of the Roche group Daiichi-Sankyo Dexa Medica Expertise for the Promotion of health Eisai first PHARMACEUTICAL FivePrime FOBENI FUJIFILM Genentech IN BUSINESS FOR LIFE gsk HELSINN Building quality cancer care together Hisamitsu Humanigen IDC Theranostics Immunas Pharma inibsa HOSPITAL INTAS janssen JB Japan Blood Products Organization Jazz Pharmaceuticals LEO Lonza MEI pharma meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Solasia Synaffix Syndax synmosa Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion TOYOCHEM ultragenyx pharmaceutical Winhealth Pharma WIDATRA ZUELLIG PHARMA making healthcare more accessible">
<!-- /.box-image --></div>

<!-- /.str-section --></div>
<!-- /.str-section-wrapper --></div>


<!-- /.wrapper --></div>
<!-- ======================== Main Content END =================================== -->
</main>

<!-- ======================== Footer START =================================== -->
<footer class="footer">
<div class="logo"><a href="/index.html"><img src="/share/images/logo_footer.png" alt="KYOWA KIRIN"></a></div>
<div class="footer-inner">

<ul class="footer-link">
<li><a href="/index.html">About us</a></li>
<li><a href="/what_we_do/index.html"><span class="sp-hide">Research &amp; Development</span><span class="pc-hide">R &amp; D</span></a></li>
<li><a href="/sustainability/index.html">Sustainability</a></li>
<li><a href="/stories/index.html">Stories</a></li>
<li><a href="/media_center/news_releases/index.html">News &amp; Releases</a></li>
<li><a href="/careers/index.html">Careers</a></li>
<li><a href="https://ir.kyowakirin.com/en/index.html" target="_blank">Investors<img src="/share/images/icon_link_blank_02.png" alt="Open in new window" class="icon-blank"></a></li>
<li><a href="/index.html#anc-global-network">Worldwide</a></li>
<li><a href="/contact_us/index.html">Contact us</a></li>
<li><a href="/sitemap/index.html">Sitemap</a></li>
<li><a href="/terms_and_conditions/index.html">Terms &amp; Conditions</a></li>
<li><a href="/privacy_policy/index.html">Privacy policy</a></li>
</ul>

<div class="footer-area-sub">
<!-- <ul class="footer-link-sns">
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_twitter.png" alt="twitter"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_facebook.png" alt="facebook"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_linkedin.png" alt="linkedin"></a></li>
<li><a href="$$dummy$$"><img src="/share/images/icon_sns_google.png" alt="google"></a></li>
</ul> -->
<p class="footer-copy"><small>Copyright  Kyowa Kirin Co., Ltd.   All rights reserved.</small></p>
<!-- /.footer-area-sub --></div>

<!-- /.footer-inner --></div>
</footer>
<!-- ======================== Footer END =================================== -->

<script src="/share/js/jquery-3.3.1.min.js"></script>
<script src="/share/js/outBoundModal.js" charset="UTF-8"></script>
<script src="/share/js/run.js"></script>
<script src="/share/js/search.js" defer=""></script>
<script src="/what_we_do/share/js/run.js"></script>
<script src="/share/js/kkc-animation.js" defer=""></script>
<script>
    Stickyfill.add(document.querySelectorAll('.sticky'));
</script>


<div class="box-modal-outbound"><div class="box-modal-inner"><div class="modal-tmp"></div><button class="btn-modal-close" type="button"><span class="radius"><span>Close</span></span></button></div></div><div class="box-modal-overlay is-hidden" aria-hidden="true"></div><script type="text/javascript" id="">(function(){var d=google_tag_manager["GTM-5MRQQG"].macro(214),f=google_tag_manager["GTM-5MRQQG"].macro(230),g=document.createElement("a"),e=google_tag_manager["GTM-5MRQQG"].macro(231),a=google_tag_manager["GTM-5MRQQG"].macro(232),b=google_tag_manager["GTM-5MRQQG"].macro(233),c=google_tag_manager["GTM-5MRQQG"].macro(234);"m.kirin.co.jp"===a&&"/enq/enq_form.php"===b&&0>c.indexOf("qIds\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(235)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/usr/regist.php"===b&&0>c.indexOf("qIds\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(236)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===
a&&"/enq/enq_thank.php"===b&&0>c.indexOf("qIds\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(237)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/usr/regist.php"===b&&0>c.indexOf("qSiteId\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(238)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/pg/frremind.php"===b&&0>c.indexOf("qSiteId\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(239)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/usr/index.php"===b&&0>c.indexOf("qSiteId\x3d")?
google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(240)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/enq/extenq.php"===b&&0>c.indexOf("qSiteId\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(241)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/pg/frlogin.php"===b&&0>c.indexOf("qSiteId\x3d")?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(242)].dataLayer.set("referrerForBrand",void 0):"m.kirin.co.jp"===a&&"/enq/enq_answer.php"===b?google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(243)].dataLayer.set("referrerForBrand",
void 0):("undefined"!==typeof e&&null!==e&&0<e.length?(g.href=e,f.current===f.referrer&&f.current!==d&&(g.hostname="gtmtraffic-"+a),d=g.href):d=void 0,google_tag_manager[google_tag_manager["GTM-5MRQQG"].macro(244)].dataLayer.set("referrerForBrand",d))})();</script><script type="text/javascript" id="">!function(d,f){if(void 0===f[d]){f[d]=function(){f[d].clients.push(this);this._init=[Array.prototype.slice.call(arguments)]};f[d].clients=[];for(var g=function(c){return function(){return this["_"+c]=this["_"+c]||[],this["_"+c].push(Array.prototype.slice.call(arguments)),this}},h="blockEvents unblockEvents setSignedMode setAnonymousMode resetUUID fetchServerCookie addRecord fetchGlobalID fetchUserSegments set trackEvent trackPageview trackClicks ready".split(" "),a=0;a<h.length;a++){var b=h[a];f[d].prototype[b]=
g(b)}g=document.createElement("script");g.type="text/javascript";g.async=!0;g.src=("https:"===document.location.protocol?"https:":"http:")+"//cdn.treasuredata.com/sdk/2.4/td.min.js";h=document.getElementsByTagName("script")[0];h.parentNode.insertBefore(g,h)}}("Treasure",this);
!function(d,f,g,h){d=function(a){this.version="0.3.3";this.customParam=a.customParam||{};this.idSyncList=a.idSyncList||[];this.table=a.table;this.trackClicks=a.trackClicks||!1;this.trackCrossDomain=a.trackCrossDomain||!1;this.trackTealiumId=a.trackTealiumId||!1;this.id="tdw_"+Math.random().toString(36).substring(7);this.sent=!1;this.tokenAudienceOne=a.tokenAudienceOne||void 0;this.clickTable=a.clickTable||"clicks";this.dmpCb={list:{},funcs:[],cnt:0};this.ac=this._getAccountInfo(a.initParams);this.useSsc=
a.initParams.useServerSideCookie||!1;var b=new f.Treasure(a.initParams);return b.set("$global",this.customParam),this.trackCrossDomain&&b.set("$global","td_global_id","td_global_id"),this.success=this._prepareSuccessCallback(a.successCallback||[]),this.fail=a.errorCallback||void 0,this.td=b,f[h][this.id]=this,this};d.prototype._getAccountInfo=function(a){var b=a.writeKey.split("/")[0];return this._getPlatformInfo(a.host.split(".")[0])+"-"+b};d.prototype._getPlatformInfo=function(a){return"in"===a?
"aws-us":"tokyo"===a?"aws-tokyo":"idcf"===a?"idcf":"unknown-"+a};d.prototype._setDmpCallbacks=function(){if(void 0!==this.tokenAudienceOne){var a={parent:this,onReceive:function(c){var e={};void 0!==c.aoneuid&&(e.aoneuid=c.aoneuid);void 0!==c.segmentIds&&(e.aone_segmentids=c.segmentIds);void 0!==c.aonesegments&&(void 0!==c.aonesegments.demographic&&(e.aone_demographic=c.aonesegments.demographic),void 0!==c.aonesegments.interest&&(e.aone_interest=c.aonesegments.interest),void 0!==c.aonesegments.zipcode&&
(e.aone_zipcode_home=c.aonesegments.zipcode.home,e.aone_zipcode_work=c.aonesegments.zipcode.work));this.parent._onDmpCallback(e)}},b="penta.a.one.impact-ad.jp/dd?oid\x3d"+this.tokenAudienceOne+"\x26rft\x3dk\x26jsonp\x3d"+h+"."+this.id+".dmpCb.list.aone.onReceive\x26tgsrc\x3dtd";this.dmpCb.list.aone=a;this.dmpCb.funcs.push(this._buildCreateScriptFunc(b))}};d.prototype._onDmpCallback=function(a){this.td.set("$global",a);this.dmpCb.cnt++;Object.keys(this.dmpCb.list).length===this.dmpCb.cnt&&this.sendRequest()};
d.prototype._getCookie=function(a){var b,c,e,k=document.cookie.split(";");for(b=0;b<k.length;b++)if(c=k[b].substr(0,k[b].indexOf("\x3d")),e=k[b].substr(k[b].indexOf("\x3d")+1),(c=c.replace(/^\s+|\s+$/g,""))===a)return decodeURIComponent(e);return""};d.prototype._prepareSuccessCallback=function(a){var b=[];if(("function"==typeof a&&b.push(a),0!==this.idSyncList.length)&&0<=this.idSyncList.indexOf("google")){var c=this;b.push(function(){var e;var k="\x26td_client_id\x3d"+c.td.client.track.uuid+"\x26td_host\x3d"+
document.location.host+"\x26account\x3d"+c.ac;k="cm.g.doubleclick.net/pixel?google_nid\x3dtreasuredata_dmp\x26google_cm\x26td_write_key\x3d8151/fcd628065149d648b80f11448b4083528c0d8a91\x26td_global_id\x3dtd_global_id"+k;(e=document.createElement("img")).src="https://"+k;e.width=1;e.height=1;e.style.display="none";document.body.appendChild(e)})}return function(){b.forEach(function(e){e()})}};d.prototype._buildCreateScriptFunc=function(a){return function(){var b=a,c=g.createElement("script");c.type=
"text/javascript";c.async=!0;c.src="https://"+b;b=g.getElementsByTagName("script")[0];b.parentNode.insertBefore(c,b)}};d.prototype._fireEvents=function(a){a.td.trackEvent(a.table,{},a.success,a.fail);a.trackClicks&&a.td.trackClicks({tableName:a.clickTable})};d.prototype._getSscFlg=function(a){return a.useSsc&&void 0!==a.td.fetchServerCookie};d.prototype._trackEvent=function(a){a._getSscFlg(a)?a.td.fetchServerCookie(function(b){a.td.set("$global",{td_ssc_id:b});a._fireEvents(a)},function(){a._fireEvents(a)}):
a._fireEvents(a)};d.prototype.sendRequest=function(){this.sent||(this._trackEvent(this),this.sent=!0)};d.prototype.boot=function(){this._setDmpCallbacks();0!==this.dmpCb.funcs.length?this.dmpCb.funcs.forEach(function(a){a()}):this.sendRequest()};f[h]=d}(0,window,document,"TDWrapper_");
var _opts={initParams:{host:"in.treasuredata.com",writeKey:"8905/888943cd0943f1fd3a1acec453f92e3f31bafdb6",database:"1_original",startInSignedMode:!0},table:"accesslog",tokenAudienceOne:"633b02ab034d8d97",customParam:{vncid:"krn01",vnuid1:google_tag_manager["GTM-5MRQQG"].macro(282),vnuid2:google_tag_manager["GTM-5MRQQG"].macro(283)},trackCrossDomain:!0,idSyncList:["google"]},tdw=new TDWrapper_(_opts);tdw.boot();</script><script type="text/javascript" id="" src="//img.macromill.com/lgncs/krsyc/km.php"></script><script type="text/javascript" id="">var _gaq=[];</script><script type="text/javascript" id="">(function(){function g(b,c){return function(a){h(b.hostname)&&(a=k(b.hostname,b.pathname),ga(c+".linker:decorate",b,a))}}if("function"===typeof ga){var k=google_tag_manager["GTM-5MRQQG"].macro(292),h=google_tag_manager["GTM-5MRQQG"].macro(294);ga(function(){var b="";for(var c=ga.getAll(),a=0;a<c.length;a++){var d=c[a],e=d.get("trackingId");"UA-71637565-16"===e&&(b=d.get("name"))}if(b)for(ga(b+".require","linker"),c=document.getElementsByTagName("a"),a=0;a<c.length;a++)if("_blank"===c[a].target){d=c[a];e="mousedown";var f=g(c[a],b);d.addEventListener?
d.addEventListener(e,f):d.attachEvent("on"+e,f)}})}})();</script><div style="display: none; visibility: hidden;">
<script type="text/javascript" src="https://cdn-apac.onetrust.com/consent/aab40d14-19da-4341-9774-eee9f5556dc4/OtAutoBlock.js"></script>
<script src="https://cdn-apac.onetrust.com/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="aab40d14-19da-4341-9774-eee9f5556dc4"></script>
<script type="text/javascript">function OptanonWrapper(){};</script>
</div><script type="text/javascript" id="" src="//csm.cxpublic.com/KIRIN.js"></script><img class="optanon-category-C0004" width="1" height="1" style="display: none;" src="https://cm.g.doubleclick.net/pixel?google_nid=treasuredata_dmp&amp;google_cm&amp;td_write_key=8151/fcd628065149d648b80f11448b4083528c0d8a91&amp;td_global_id=td_global_id&amp;td_client_id=bf9c363f-7345-4b28-9f66-7082c8fca152&amp;td_host=www.kyowakirin.com&amp;account=aws-us-8905"><iframe id="cx_rep_iframe_0.8981065725576762" name="cx_rep_iframe_0.8981065725576762" width="1" height="1" src="https://cdn.cxense.com/sp1.html#ver=2.6.5&amp;typ=pgv&amp;rnd=l75igkroc1u9iyfr&amp;sid=1140895804611220048&amp;loc=https%3A%2F%2Fwww.kyowakirin.com%2Fwhat_we_do%2Findex.html%23anc-pipeline&amp;new=1&amp;arf=0&amp;ltm=1661218259750&amp;ref=&amp;tzo=180&amp;wsz=2800x1080&amp;res=1512x982&amp;dpr=2&amp;col=30&amp;bln=en-US&amp;chs=UTF-8&amp;cks=l75iglebldnst1z9&amp;ckp=l75igkrorqcau811&amp;glb=&amp;cp_userState=anon&amp;cp_newuser=true&amp;cp_hour=22&amp;cp_wday=Mon&amp;cp_ver=2.47&amp;cp_testGroup=60&amp;cp_newuser_S=true" scrolling="no" frameborder="0" style="display: none;"></iframe><div id="cxPopup"><div id="cce-empty-element"></div></div><div id="onetrust-consent-sdk"><div class="onetrust-pc-dark-filter ot-hide ot-fade-in" style="display: none;
                    transition: visibility 0s 400ms, opacity 400ms linear;
                    opacity: 0;visibility: hidden;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title vertical-align-content" tabindex="0" style="display: none;bottom: 0px;visibility: hidden;
                    opacity: 0;transition: visibility 0s 400ms, opacity 400ms linear;"><div role="alertdialog" aria-describedby="onetrust-policy-text" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><p id="onetrust-policy-text">We use cookies to improve your experience on our website, to personalise content and ads, to provide social media features and to analyse our traffic. We share information about your use of our website with our social media, advertising and analytics partners, who may combine it with other information that you have provided to them or that they have collected from your use of their services.Please click [Cookie Settings] to customize your cookie settings on our website.</p></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns has-reject-all-button"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookies Settings</button> <button id="onetrust-reject-all-handler">Reject All</button> <button id="onetrust-accept-btn-handler">Accept All Cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcTab ot-hide ot-fade-in" role="alertdialog" aria-modal="true" aria-describedby="ot-pc-desc" lang="en" aria-label="Privacy Preference Center" style="display: none;
                    transition: visibility 0s 400ms, opacity 400ms linear;
                    opacity: 0;visibility: hidden;"><!-- pc header --><div class="ot-pc-header" role="presentation"><!-- Header logo --><div class="ot-pc-logo" role="img" aria-label="Company Logo" style="background-image: url(&quot;https://cdn-apac.onetrust.com/logos/771d2300-6d04-4d70-995b-0e9292c8a01f/3337f576-0487-42a1-8ff4-ad0aa8437789/a7c9fd93-a62c-4bfe-87f2-7237c5ac2855/logo_header_01.png&quot;);
                    background-position: left;"></div><div class="ot-title-cntr"><h2 id="ot-pc-title">Privacy Preference Center</h2><div class="ot-close-cntr"><button id="close-pc-btn-handler" class="ot-close-icon" aria-label="Close"></button></div></div></div><!-- content --><!-- Groups / Sub groups with cookies --><div id="ot-pc-content" class="ot-pc-scrollbar ot-sdk-row"><div class="ot-sdk-container ot-grps-cntr ot-sdk-column"><div class="ot-sdk-four ot-sdk-columns ot-tab-list" aria-label="Cookie Categories"><ul class="ot-cat-grp" role="tablist"><li class="ot-abt-tab" role="presentation"><!-- About Privacy container --><div class="ot-active-menu category-menu-switch-handler" role="tab" tabindex="0" aria-selected="true" aria-controls="ot-tab-desc"><h3 id="ot-pvcy-txt">Your Privacy</h3></div></li><li class="ot-cat-item ot-always-active-group" role="presentation" data-optanongroupid="C0001"><div class="category-menu-switch-handler" role="tab" tabindex="-1" aria-selected="false" aria-controls="ot-desc-id-C0001"><h3 id="ot-header-id-C0001">Strictly Necessary Cookies</h3></div></li><li class="ot-cat-item" role="presentation" data-optanongroupid="C0002"><div class="category-menu-switch-handler" role="tab" tabindex="-1" aria-selected="false" aria-controls="ot-desc-id-C0002"><h3 id="ot-header-id-C0002">Performance Cookies</h3></div></li><li class="ot-cat-item" role="presentation" data-optanongroupid="C0003"><div class="category-menu-switch-handler" role="tab" tabindex="-1" aria-selected="false" aria-controls="ot-desc-id-C0003"><h3 id="ot-header-id-C0003">Functional Cookies</h3></div></li><li class="ot-cat-item" role="presentation" data-optanongroupid="C0004"><div class="category-menu-switch-handler" role="tab" tabindex="-1" aria-selected="false" aria-controls="ot-desc-id-C0004"><h3 id="ot-header-id-C0004">Targeting Cookies</h3></div></li></ul></div><div class="ot-tab-desc ot-sdk-eight ot-sdk-columns"><div class="ot-desc-cntr" id="ot-tab-desc" tabindex="0" role="tabpanel" aria-labelledby="ot-pvcy-hdr"><h4 id="ot-pvcy-hdr">Your Privacy</h4><p id="ot-pc-desc" class="ot-grp-desc">When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
                <br><a href="https://www.kyowakirin.com/privacy_policy/index.html" class="privacy-notice-link" rel="noopener" target="_blank" aria-label="More information about your privacy, opens in a new tab">More information</a></p></div><div class="ot-desc-cntr ot-hide ot-always-active-group" role="tabpanel" tabindex="0" id="ot-desc-id-C0001"><div class="ot-grp-hdr1"><h4 class="ot-cat-header">Strictly Necessary Cookies</h4><div class="ot-tgl-cntr"><div class="ot-always-active">Always Active</div></div></div><p class="ot-grp-desc ot-category-desc">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. &nbsp; &nbsp;You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.</p></div><div class="ot-desc-cntr ot-hide" role="tabpanel" tabindex="0" id="ot-desc-id-C0002"><div class="ot-grp-hdr1"><h4 class="ot-cat-header">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-C0002" id="ot-group-id-C0002" aria-checked="true" role="switch" class="category-switch-handler" data-optanongroupid="C0002" aria-labelledby="ot-header-id-C0002" checked=""> <label class="ot-switch" for="ot-group-id-C0002"><span class="ot-switch-nob" aria-checked="false" role="switch"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div><div class="ot-tgl-cntr"></div></div><p class="ot-grp-desc ot-category-desc">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. &nbsp; &nbsp;All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.</p></div><div class="ot-desc-cntr ot-hide" role="tabpanel" tabindex="0" id="ot-desc-id-C0003"><div class="ot-grp-hdr1"><h4 class="ot-cat-header">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-C0003" id="ot-group-id-C0003" aria-checked="true" role="switch" class="category-switch-handler" data-optanongroupid="C0003" aria-labelledby="ot-header-id-C0003" checked=""> <label class="ot-switch" for="ot-group-id-C0003"><span class="ot-switch-nob" aria-checked="false" role="switch"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div><div class="ot-tgl-cntr"></div></div><p class="ot-grp-desc ot-category-desc">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. &nbsp; &nbsp;If you do not allow these cookies then some or all of these services may not function properly.</p></div><div class="ot-desc-cntr ot-hide" role="tabpanel" tabindex="0" id="ot-desc-id-C0004"><div class="ot-grp-hdr1"><h4 class="ot-cat-header">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-C0004" id="ot-group-id-C0004" aria-checked="true" role="switch" class="category-switch-handler" data-optanongroupid="C0004" aria-labelledby="ot-header-id-C0004" checked=""> <label class="ot-switch" for="ot-group-id-C0004"><span class="ot-switch-nob" aria-checked="false" role="switch"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div><div class="ot-tgl-cntr"></div></div><p class="ot-grp-desc ot-category-desc">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. &nbsp; &nbsp;They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.</p></div></div></div></div><!-- Vendors / Hosts --><section id="ot-pc-lst" class="ot-hide ot-enbl-chr"><div class="ot-lst-cntr ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                  l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                  c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                  s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                  L213.13,222.409z"></path></g></svg></button><h3>Back</h3></div><div class="ot-lst-subhdr"><div id="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><label for="vendor-search-handler" class="ot-scrn-rdr"></label> <input id="vendor-search-handler" type="text" name="vendor-search-handler"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
              s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
              c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
              s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div id="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Button</title><g><path fill="#2c3643" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
                            c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
                            c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
                            C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div></div></div><section id="ot-lst-cnt" class="ot-pc-scrollbar"><div class="ot-sdk-row"><div class="ot-sdk-column"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox" aria-checked="false"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox" aria-checked="false"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox" aria-checked="false"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div></div></div></section></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts"><div class="ot-fltr-opt"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" aria-checked="false" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></section><!-- Footer buttons and logo --><div class="ot-pc-footer"><div class="ot-btn-container"><button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm My Choices</button><div class="ot-btn-subcntr"> <button id="accept-recommended-btn-handler">Allow All</button></div></div><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn-apac.onetrust.com/logos/static/poweredBy_ot_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite">Your Privacy [`dialog closed`]</span><iframe class="ot-text-resize" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><script type="text/javascript" async="" src="https://cache.dga.jp/s/kirin/new_i_search_assist.js"></script><link type="text/css" rel="stylesheet" href="https://cache.dga.jp/s/kirin/new_ac.css"></body></html>